id	sid	tid	token	lemma	pos
bam-9161	1	1	microsoft	microsoft	PROPN
bam-9161	1	2	word	word	PROPN
bam-9161	1	3	ejtm30(3	ejtm30(3	PROPN
bam-9161	1	4	)	)	PUNCT
bam-9161	1	5	#	#	SYM
bam-9161	1	6	9161	9161	NUM
bam-9161	1	7	co	co	NOUN
bam-9161	1	8	-	-	NOUN
bam-9161	1	9	bahoush	bahoush	ADJ
bam-9161	1	10	final.1	final.1	PROPN
bam-9161	1	11	oct05.docx	oct05.docx	VERB
bam-9161	1	12	severe	severe	ADJ
bam-9161	1	13	veno	veno	NOUN
bam-9161	1	14	-	-	PUNCT
bam-9161	1	15	occlusive	occlusive	NOUN
bam-9161	1	16	disease	disease	NOUN
bam-9161	1	17	eur	eur	PROPN
bam-9161	1	18	j	j	PROPN
bam-9161	1	19	transl	transl	PROPN
bam-9161	1	20	myol	myol	NOUN
bam-9161	1	21	2020	2020	NUM
bam-9161	1	22	;	;	PUNCT
bam-9161	1	23	30	30	NUM
bam-9161	1	24	(	(	PUNCT
bam-9161	1	25	3	3	NUM
bam-9161	1	26	):	):	PUNCT
bam-9161	1	27	9161	9161	NUM
bam-9161	1	28	.	.	PUNCT
bam-9161	2	1	doi	doi	NOUN
bam-9161	2	2	:	:	PUNCT
bam-9161	2	3	10.4081	10.4081	NUM
bam-9161	2	4	/	/	SYM
bam-9161	2	5	ejtm.2020.9161	ejtm.2020.9161	ADJ
bam-9161	2	6	1	1	NUM
bam-9161	2	7	a	a	DET
bam-9161	2	8	case	case	NOUN
bam-9161	2	9	report	report	NOUN
bam-9161	2	10	of	of	ADP
bam-9161	2	11	severe	severe	ADJ
bam-9161	2	12	veno	veno	NOUN
bam-9161	2	13	-	-	PUNCT
bam-9161	2	14	occlusive	occlusive	NOUN
bam-9161	2	15	disease	disease	NOUN
bam-9161	2	16	following	follow	VERB
bam-9161	2	17	autologous	autologous	ADJ
bam-9161	2	18	stem	stem	NOUN
bam-9161	2	19	cell	cell	NOUN
bam-9161	2	20	transplantation	transplantation	NOUN
bam-9161	2	21	successfully	successfully	ADV
bam-9161	2	22	treated	treat	VERB
bam-9161	2	23	with	with	ADP
bam-9161	2	24	defibrotide	defibrotide	PROPN
bam-9161	2	25	golamreza	golamreza	PROPN
bam-9161	2	26	bahoush	bahoush	PROPN
bam-9161	2	27	,	,	PUNCT
bam-9161	2	28	maryam	maryam	PROPN
bam-9161	2	29	vafapour	vafapour	PROPN
bam-9161	2	30	ali	ali	PROPN
bam-9161	2	31	-	-	PUNCT
bam-9161	2	32	asghar	asghar	PROPN
bam-9161	2	33	children	children	PROPN
bam-9161	2	34	hospital	hospital	NOUN
bam-9161	2	35	,	,	PUNCT
bam-9161	2	36	faculty	faculty	NOUN
bam-9161	2	37	of	of	ADP
bam-9161	2	38	medicine	medicine	NOUN
bam-9161	2	39	,	,	PUNCT
bam-9161	2	40	iran	iran	PROPN
bam-9161	2	41	university	university	PROPN
bam-9161	2	42	of	of	ADP
bam-9161	2	43	medical	medical	ADJ
bam-9161	2	44	sciences	sciences	PROPN
bam-9161	2	45	,	,	PUNCT
bam-9161	2	46	tehran	tehran	PROPN
bam-9161	2	47	,	,	PUNCT
bam-9161	2	48	iran	iran	PROPN
bam-9161	2	49	.	.	PUNCT
bam-9161	3	1	this	this	DET
bam-9161	3	2	article	article	NOUN
bam-9161	3	3	is	be	AUX
bam-9161	3	4	distributed	distribute	VERB
bam-9161	3	5	under	under	ADP
bam-9161	3	6	the	the	DET
bam-9161	3	7	terms	term	NOUN
bam-9161	3	8	of	of	ADP
bam-9161	3	9	the	the	DET
bam-9161	3	10	creative	creative	ADJ
bam-9161	3	11	commons	common	NOUN
bam-9161	3	12	attribution	attribution	NOUN
bam-9161	3	13	noncommercial	noncommercial	ADJ
bam-9161	3	14	license	license	NOUN
bam-9161	3	15	(	(	PUNCT
bam-9161	3	16	cc	cc	NOUN
bam-9161	3	17	by	by	ADP
bam-9161	3	18	-	-	PUNCT
bam-9161	3	19	nc	nc	PROPN
bam-9161	3	20	4.0	4.0	NUM
bam-9161	3	21	)	)	PUNCT
bam-9161	3	22	which	which	PRON
bam-9161	3	23	permits	permit	VERB
bam-9161	3	24	any	any	DET
bam-9161	3	25	noncommercial	noncommercial	ADJ
bam-9161	3	26	use	use	NOUN
bam-9161	3	27	,	,	PUNCT
bam-9161	3	28	distribution	distribution	NOUN
bam-9161	3	29	,	,	PUNCT
bam-9161	3	30	and	and	CCONJ
bam-9161	3	31	reproduction	reproduction	NOUN
bam-9161	3	32	in	in	ADP
bam-9161	3	33	any	any	DET
bam-9161	3	34	medium	medium	NOUN
bam-9161	3	35	,	,	PUNCT
bam-9161	3	36	provided	provide	VERB
bam-9161	3	37	the	the	DET
bam-9161	3	38	original	original	ADJ
bam-9161	3	39	author(s	author(s	NOUN
bam-9161	3	40	)	)	PUNCT
bam-9161	3	41	and	and	CCONJ
bam-9161	3	42	source	source	NOUN
bam-9161	3	43	are	be	AUX
bam-9161	3	44	credited	credit	VERB
bam-9161	3	45	.	.	PUNCT
bam-9161	4	1	abstract	abstract	ADJ
bam-9161	4	2	veno	veno	NOUN
bam-9161	4	3	-	-	PUNCT
bam-9161	4	4	occlusive	occlusive	NOUN
bam-9161	4	5	disease	disease	NOUN
bam-9161	4	6	(	(	PUNCT
bam-9161	4	7	vod	vod	NOUN
bam-9161	4	8	)	)	PUNCT
bam-9161	4	9	is	be	AUX
bam-9161	4	10	one	one	NUM
bam-9161	4	11	of	of	ADP
bam-9161	4	12	the	the	DET
bam-9161	4	13	complications	complication	NOUN
bam-9161	4	14	of	of	ADP
bam-9161	4	15	hematopoietic	hematopoietic	ADJ
bam-9161	4	16	stem	stem	NOUN
bam-9161	4	17	cell	cell	NOUN
bam-9161	4	18	transplantation	transplantation	NOUN
bam-9161	4	19	that	that	PRON
bam-9161	4	20	can	can	AUX
bam-9161	4	21	also	also	ADV
bam-9161	4	22	be	be	AUX
bam-9161	4	23	caused	cause	VERB
bam-9161	4	24	by	by	ADP
bam-9161	4	25	high	high	ADJ
bam-9161	4	26	-	-	PUNCT
bam-9161	4	27	dose	dose	NOUN
bam-9161	4	28	chemotherapy	chemotherapy	NOUN
bam-9161	4	29	.	.	PUNCT
bam-9161	5	1	this	this	DET
bam-9161	5	2	complication	complication	NOUN
bam-9161	5	3	can	can	AUX
bam-9161	5	4	lead	lead	VERB
bam-9161	5	5	to	to	ADP
bam-9161	5	6	high	high	ADJ
bam-9161	5	7	mortality	mortality	NOUN
bam-9161	5	8	following	follow	VERB
bam-9161	5	9	bone	bone	NOUN
bam-9161	5	10	marrow	marrow	NOUN
bam-9161	5	11	transplantation	transplantation	NOUN
bam-9161	5	12	.	.	PUNCT
bam-9161	6	1	it	it	PRON
bam-9161	6	2	is	be	AUX
bam-9161	6	3	more	more	ADV
bam-9161	6	4	common	common	ADJ
bam-9161	6	5	after	after	ADP
bam-9161	6	6	allogeneic	allogeneic	ADJ
bam-9161	6	7	stem	stem	NOUN
bam-9161	6	8	cell	cell	NOUN
bam-9161	6	9	transplantation	transplantation	NOUN
bam-9161	6	10	,	,	PUNCT
bam-9161	6	11	and	and	CCONJ
bam-9161	6	12	is	be	AUX
bam-9161	6	13	rare	rare	ADJ
bam-9161	6	14	after	after	ADP
bam-9161	6	15	autologous	autologous	ADJ
bam-9161	6	16	stem	stem	NOUN
bam-9161	6	17	cell	cell	NOUN
bam-9161	6	18	transplantation	transplantation	NOUN
bam-9161	6	19	.	.	PUNCT
bam-9161	7	1	while	while	SCONJ
bam-9161	7	2	mild	mild	ADJ
bam-9161	7	3	cases	case	NOUN
bam-9161	7	4	of	of	ADP
bam-9161	7	5	vod	vod	NOUN
bam-9161	7	6	may	may	AUX
bam-9161	7	7	reduce	reduce	VERB
bam-9161	7	8	over	over	ADP
bam-9161	7	9	a	a	DET
bam-9161	7	10	period	period	NOUN
bam-9161	7	11	of	of	ADP
bam-9161	7	12	a	a	DET
bam-9161	7	13	few	few	ADJ
bam-9161	7	14	weeks	week	NOUN
bam-9161	7	15	,	,	PUNCT
bam-9161	7	16	very	very	ADV
bam-9161	7	17	severe	severe	ADJ
bam-9161	7	18	cases	case	NOUN
bam-9161	7	19	can	can	AUX
bam-9161	7	20	cause	cause	VERB
bam-9161	7	21	multi	multi	ADJ
bam-9161	7	22	-	-	ADJ
bam-9161	7	23	organ	organ	ADJ
bam-9161	7	24	damage	damage	NOUN
bam-9161	7	25	,	,	PUNCT
bam-9161	7	26	which	which	PRON
bam-9161	7	27	has	have	VERB
bam-9161	7	28	a	a	DET
bam-9161	7	29	high	high	ADJ
bam-9161	7	30	mortality	mortality	NOUN
bam-9161	7	31	.	.	PUNCT
bam-9161	8	1	is	be	AUX
bam-9161	8	2	therefore	therefore	ADV
bam-9161	8	3	required	require	VERB
bam-9161	8	4	with	with	ADP
bam-9161	8	5	early	early	ADJ
bam-9161	8	6	diagnosis	diagnosis	NOUN
bam-9161	8	7	and	and	CCONJ
bam-9161	8	8	treatment	treatment	NOUN
bam-9161	8	9	of	of	ADP
bam-9161	8	10	this	this	DET
bam-9161	8	11	complication	complication	NOUN
bam-9161	8	12	.	.	PUNCT
bam-9161	9	1	in	in	ADP
bam-9161	9	2	this	this	DET
bam-9161	9	3	paper	paper	NOUN
bam-9161	9	4	,	,	PUNCT
bam-9161	9	5	we	we	PRON
bam-9161	9	6	present	present	VERB
bam-9161	9	7	a	a	DET
bam-9161	9	8	sever	sever	ADJ
bam-9161	9	9	vod	vod	NOUN
bam-9161	9	10	case	case	NOUN
bam-9161	9	11	after	after	ADP
bam-9161	9	12	autologous	autologous	ADJ
bam-9161	9	13	stem	stem	NOUN
bam-9161	9	14	cell	cell	NOUN
bam-9161	9	15	transplantation	transplantation	NOUN
bam-9161	9	16	,	,	PUNCT
bam-9161	9	17	that	that	PRON
bam-9161	9	18	was	be	AUX
bam-9161	9	19	treated	treat	VERB
bam-9161	9	20	successfully	successfully	ADV
bam-9161	9	21	with	with	ADP
bam-9161	9	22	defibrotide	defibrotide	NOUN
bam-9161	9	23	.	.	PUNCT
bam-9161	10	1	the	the	DET
bam-9161	10	2	patient	patient	NOUN
bam-9161	10	3	was	be	AUX
bam-9161	10	4	a	a	DET
bam-9161	10	5	14	14	NUM
bam-9161	10	6	-	-	PUNCT
bam-9161	10	7	month	month	NOUN
bam-9161	10	8	-	-	PUNCT
bam-9161	10	9	old	old	ADJ
bam-9161	10	10	girl	girl	NOUN
bam-9161	10	11	who	who	PRON
bam-9161	10	12	has	have	VERB
bam-9161	10	13	neuroblastoma	neuroblastoma	NOUN
bam-9161	10	14	with	with	ADP
bam-9161	10	15	bone	bone	NOUN
bam-9161	10	16	metastasis	metastasis	NOUN
bam-9161	10	17	.	.	PUNCT
bam-9161	11	1	vod	vod	NOUN
bam-9161	11	2	should	should	AUX
bam-9161	11	3	be	be	AUX
bam-9161	11	4	considered	consider	VERB
bam-9161	11	5	in	in	ADP
bam-9161	11	6	the	the	DET
bam-9161	11	7	differential	differential	ADJ
bam-9161	11	8	diagnosis	diagnosis	NOUN
bam-9161	11	9	of	of	ADP
bam-9161	11	10	haematopoietic	haematopoietic	ADJ
bam-9161	11	11	stem	stem	NOUN
bam-9161	11	12	cell	cell	NOUN
bam-9161	11	13	transplantation	transplantation	NOUN
bam-9161	11	14	recipients	recipient	NOUN
bam-9161	11	15	who	who	PRON
bam-9161	11	16	present	present	VERB
bam-9161	11	17	with	with	ADP
bam-9161	11	18	unexplained	unexplained	ADJ
bam-9161	11	19	liver	liver	NOUN
bam-9161	11	20	injuries	injury	NOUN
bam-9161	11	21	,	,	PUNCT
bam-9161	11	22	ascites	ascite	NOUN
bam-9161	11	23	and/or	and/or	CCONJ
bam-9161	11	24	multi	multi	VERB
bam-9161	11	25	organ	organ	NOUN
bam-9161	11	26	failure	failure	NOUN
bam-9161	11	27	.	.	PUNCT
bam-9161	12	1	recipients	recipient	NOUN
bam-9161	12	2	of	of	ADP
bam-9161	12	3	haematopoeitic	haematopoeitic	ADJ
bam-9161	12	4	stem	stem	NOUN
bam-9161	12	5	cell	cell	NOUN
bam-9161	12	6	transplantation	transplantation	NOUN
bam-9161	12	7	who	who	PRON
bam-9161	12	8	present	present	VERB
bam-9161	12	9	with	with	ADP
bam-9161	12	10	unexplained	unexplained	ADJ
bam-9161	12	11	liver	liver	NOUN
bam-9161	12	12	injuries	injury	NOUN
bam-9161	12	13	,	,	PUNCT
bam-9161	12	14	ascites	ascite	NOUN
bam-9161	12	15	and/or	and/or	CCONJ
bam-9161	12	16	multi	multi	VERB
bam-9161	12	17	organ	organ	NOUN
bam-9161	12	18	failure	failure	NOUN
bam-9161	12	19	should	should	AUX
bam-9161	12	20	have	have	VERB
bam-9161	12	21	vod	vod	NOUN
bam-9161	12	22	considered	consider	VERB
bam-9161	12	23	in	in	ADP
bam-9161	12	24	their	their	PRON
bam-9161	12	25	differential	differential	ADJ
bam-9161	12	26	diagnosis	diagnosis	NOUN
bam-9161	12	27	.	.	PUNCT
bam-9161	13	1	if	if	SCONJ
bam-9161	13	2	there	there	PRON
bam-9161	13	3	is	be	VERB
bam-9161	13	4	severe	severe	ADJ
bam-9161	13	5	vod	vod	NOUN
bam-9161	13	6	diagnosed	diagnose	VERB
bam-9161	13	7	,	,	PUNCT
bam-9161	13	8	then	then	ADV
bam-9161	13	9	defibrotide	defibrotide	NOUN
bam-9161	13	10	could	could	AUX
bam-9161	13	11	be	be	AUX
bam-9161	13	12	an	an	DET
bam-9161	13	13	option	option	NOUN
bam-9161	13	14	for	for	ADP
bam-9161	13	15	treatment	treatment	NOUN
bam-9161	13	16	.	.	PUNCT
bam-9161	14	1	key	key	ADJ
bam-9161	14	2	words	word	NOUN
bam-9161	14	3	:	:	PUNCT
bam-9161	14	4	neuroblastoma	neuroblastoma	ADJ
bam-9161	14	5	,	,	PUNCT
bam-9161	14	6	hematopoietic	hematopoietic	ADJ
bam-9161	14	7	stem	stem	NOUN
bam-9161	14	8	cell	cell	NOUN
bam-9161	14	9	transplantation	transplantation	NOUN
bam-9161	14	10	,	,	PUNCT
bam-9161	14	11	veno	veno	NOUN
bam-9161	14	12	-	-	PUNCT
bam-9161	14	13	occlusive	occlusive	NOUN
bam-9161	14	14	disease	disease	NOUN
bam-9161	14	15	,	,	PUNCT
bam-9161	14	16	defibrotide	defibrotide	NOUN
bam-9161	14	17	.	.	PUNCT
bam-9161	15	1	eur	eur	PROPN
bam-9161	15	2	j	j	PROPN
bam-9161	15	3	transl	transl	PROPN
bam-9161	15	4	myol	myol	ADV
bam-9161	15	5	2020;30	2020;30	PROPN
bam-9161	15	6	(	(	PUNCT
bam-9161	15	7	3	3	NUM
bam-9161	15	8	):	):	PUNCT
bam-9161	15	9	9161	9161	NUM
bam-9161	15	10	.	.	PUNCT
bam-9161	16	1	doi10.4081	doi10.4081	PROPN
bam-9161	16	2	/	/	SYM
bam-9161	16	3	ejtm.0.9161	ejtm.0.9161	PUNCT
bam-9161	16	4	following	follow	VERB
bam-9161	16	5	hematopoietic	hematopoietic	ADJ
bam-9161	16	6	stem	stem	NOUN
bam-9161	16	7	cell	cell	NOUN
bam-9161	16	8	transplantation	transplantation	NOUN
bam-9161	16	9	,	,	PUNCT
bam-9161	16	10	patients	patient	NOUN
bam-9161	16	11	may	may	AUX
bam-9161	16	12	develop	develop	VERB
bam-9161	16	13	some	some	DET
bam-9161	16	14	complications	complication	NOUN
bam-9161	16	15	,	,	PUNCT
bam-9161	16	16	one	one	NUM
bam-9161	16	17	of	of	ADP
bam-9161	16	18	which	which	PRON
bam-9161	16	19	is	be	AUX
bam-9161	16	20	the	the	DET
bam-9161	16	21	hepatic	hepatic	ADJ
bam-9161	16	22	sinusoidal	sinusoidal	ADJ
bam-9161	16	23	obstruction	obstruction	NOUN
bam-9161	16	24	syndrome	syndrome	NOUN
bam-9161	16	25	(	(	PUNCT
bam-9161	16	26	sos	sos	PROPN
bam-9161	16	27	)	)	PUNCT
bam-9161	16	28	,	,	PUNCT
bam-9161	16	29	previously	previously	ADV
bam-9161	16	30	termed	term	VERB
bam-9161	16	31	hepatic	hepatic	ADJ
bam-9161	16	32	veno	veno	NOUN
bam-9161	16	33	-	-	PUNCT
bam-9161	16	34	occlusive	occlusive	NOUN
bam-9161	16	35	disease	disease	NOUN
bam-9161	16	36	(	(	PUNCT
bam-9161	16	37	vod	vod	NOUN
bam-9161	16	38	)	)	PUNCT
bam-9161	16	39	.	.	PUNCT
bam-9161	17	1	it	it	PRON
bam-9161	17	2	usually	usually	ADV
bam-9161	17	3	occurs	occur	VERB
bam-9161	17	4	during	during	ADP
bam-9161	17	5	the	the	DET
bam-9161	17	6	first	first	ADJ
bam-9161	17	7	21	21	NUM
bam-9161	17	8	days	day	NOUN
bam-9161	17	9	of	of	ADP
bam-9161	17	10	the	the	DET
bam-9161	17	11	transplant	transplant	NOUN
bam-9161	17	12	,	,	PUNCT
bam-9161	17	13	however	however	ADV
bam-9161	17	14	it	it	PRON
bam-9161	17	15	can	can	AUX
bam-9161	17	16	also	also	ADV
bam-9161	17	17	occur	occur	VERB
bam-9161	17	18	after	after	ADP
bam-9161	17	19	chemotherapy	chemotherapy	VERB
bam-9161	17	20	alone.1	alone.1	PROPN
bam-9161	17	21	the	the	DET
bam-9161	17	22	incidence	incidence	NOUN
bam-9161	17	23	of	of	ADP
bam-9161	17	24	the	the	DET
bam-9161	17	25	disease	disease	NOUN
bam-9161	17	26	in	in	ADP
bam-9161	17	27	children	child	NOUN
bam-9161	17	28	after	after	ADP
bam-9161	17	29	hematopoietic	hematopoietic	ADJ
bam-9161	17	30	stem	stem	NOUN
bam-9161	17	31	cell	cell	NOUN
bam-9161	17	32	transplantation	transplantation	NOUN
bam-9161	17	33	(	(	PUNCT
bam-9161	17	34	hsct	hsct	PROPN
bam-9161	17	35	)	)	PUNCT
bam-9161	17	36	has	have	AUX
bam-9161	17	37	been	be	AUX
bam-9161	17	38	reported	report	VERB
bam-9161	17	39	to	to	ADP
bam-9161	17	40	22	22	NUM
bam-9161	17	41	-	-	SYM
bam-9161	17	42	30	30	NUM
bam-9161	17	43	%	%	NOUN
bam-9161	17	44	,	,	PUNCT
bam-9161	17	45	but	but	CCONJ
bam-9161	17	46	in	in	ADP
bam-9161	17	47	high	high	ADJ
bam-9161	17	48	-	-	PUNCT
bam-9161	17	49	risk	risk	NOUN
bam-9161	17	50	groups	group	NOUN
bam-9161	17	51	it	it	PRON
bam-9161	17	52	may	may	AUX
bam-9161	17	53	increase	increase	VERB
bam-9161	17	54	up	up	ADV
bam-9161	17	55	to	to	ADP
bam-9161	17	56	60%.2	60%.2	NOUN
bam-9161	17	57	there	there	PRON
bam-9161	17	58	are	be	VERB
bam-9161	17	59	various	various	ADJ
bam-9161	17	60	risk	risk	NOUN
bam-9161	17	61	factors	factor	NOUN
bam-9161	17	62	for	for	ADP
bam-9161	17	63	this	this	DET
bam-9161	17	64	complication	complication	NOUN
bam-9161	17	65	,	,	PUNCT
bam-9161	17	66	such	such	ADJ
bam-9161	17	67	as	as	ADP
bam-9161	17	68	transplant	transplant	NOUN
bam-9161	17	69	factors	factor	NOUN
bam-9161	17	70	(	(	PUNCT
bam-9161	17	71	e.g.	e.g.	ADV
bam-9161	17	72	,	,	PUNCT
bam-9161	17	73	the	the	DET
bam-9161	17	74	toxicity	toxicity	NOUN
bam-9161	17	75	of	of	ADP
bam-9161	17	76	chemotherapy	chemotherapy	NOUN
bam-9161	17	77	,	,	PUNCT
bam-9161	17	78	allogeneic	allogeneic	ADJ
bam-9161	17	79	transplant	transplant	NOUN
bam-9161	17	80	)	)	PUNCT
bam-9161	17	81	,	,	PUNCT
bam-9161	17	82	patient	patient	ADJ
bam-9161	17	83	profile	profile	NOUN
bam-9161	17	84	(	(	PUNCT
bam-9161	17	85	e.g.	e.g.	ADV
bam-9161	17	86	,	,	PUNCT
bam-9161	17	87	age	age	NOUN
bam-9161	17	88	,	,	PUNCT
bam-9161	17	89	female	female	ADJ
bam-9161	17	90	gender	gender	NOUN
bam-9161	17	91	,	,	PUNCT
bam-9161	17	92	underlying	underlying	ADJ
bam-9161	17	93	disease	disease	NOUN
bam-9161	17	94	,	,	PUNCT
bam-9161	17	95	genetic	genetic	ADJ
bam-9161	17	96	aptitude	aptitude	NOUN
bam-9161	17	97	)	)	PUNCT
bam-9161	17	98	,	,	PUNCT
bam-9161	17	99	and	and	CCONJ
bam-9161	17	100	hepatic	hepatic	ADJ
bam-9161	17	101	conditions	condition	NOUN
bam-9161	17	102	(	(	PUNCT
bam-9161	17	103	e.g.	e.g.	ADV
bam-9161	17	104	,	,	PUNCT
bam-9161	17	105	previous	previous	ADJ
bam-9161	17	106	liver	liver	NOUN
bam-9161	17	107	disease	disease	NOUN
bam-9161	17	108	,	,	PUNCT
bam-9161	17	109	immature	immature	ADJ
bam-9161	17	110	liver	liver	NOUN
bam-9161	17	111	function	function	NOUN
bam-9161	17	112	in	in	ADP
bam-9161	17	113	infants	infant	NOUN
bam-9161	17	114	,	,	PUNCT
bam-9161	17	115	iron	iron	NOUN
bam-9161	17	116	overload	overload	NOUN
bam-9161	17	117	,	,	PUNCT
bam-9161	17	118	liver	liver	NOUN
bam-9161	17	119	fibrosis	fibrosis	NOUN
bam-9161	17	120	,	,	PUNCT
bam-9161	17	121	hepatitis).3,4	hepatitis).3,4	ADJ
bam-9161	17	122	the	the	DET
bam-9161	17	123	pathogenesis	pathogenesis	NOUN
bam-9161	17	124	of	of	ADP
bam-9161	17	125	this	this	DET
bam-9161	17	126	disease	disease	NOUN
bam-9161	17	127	involves	involve	VERB
bam-9161	17	128	a	a	DET
bam-9161	17	129	number	number	NOUN
bam-9161	17	130	of	of	ADP
bam-9161	17	131	inflammatory	inflammatory	ADJ
bam-9161	17	132	and	and	CCONJ
bam-9161	17	133	thrombotic	thrombotic	ADJ
bam-9161	17	134	factors	factor	NOUN
bam-9161	17	135	that	that	PRON
bam-9161	17	136	cause	cause	VERB
bam-9161	17	137	damage	damage	NOUN
bam-9161	17	138	to	to	ADP
bam-9161	17	139	the	the	DET
bam-9161	17	140	sinusoidal	sinusoidal	ADJ
bam-9161	17	141	endothelial	endothelial	ADJ
bam-9161	17	142	cells	cell	NOUN
bam-9161	17	143	of	of	ADP
bam-9161	17	144	the	the	DET
bam-9161	17	145	liver.5	liver.5	PROPN
bam-9161	17	146	following	follow	VERB
bam-9161	17	147	narrowing	narrowing	NOUN
bam-9161	17	148	of	of	ADP
bam-9161	17	149	the	the	DET
bam-9161	17	150	the	the	DET
bam-9161	17	151	lumen	luman	NOUN
bam-9161	17	152	of	of	ADP
bam-9161	17	153	veins	vein	NOUN
bam-9161	17	154	,	,	PUNCT
bam-9161	17	155	post	post	ADJ
bam-9161	17	156	-	-	ADJ
bam-9161	17	157	sinusoidal	sinusoidal	ADJ
bam-9161	17	158	portal	portal	ADJ
bam-9161	17	159	hypertension	hypertension	NOUN
bam-9161	17	160	occurs	occur	VERB
bam-9161	17	161	and	and	CCONJ
bam-9161	17	162	can	can	AUX
bam-9161	17	163	progress	progress	VERB
bam-9161	17	164	to	to	ADP
bam-9161	17	165	the	the	DET
bam-9161	17	166	clinical	clinical	ADJ
bam-9161	17	167	symptoms	symptom	NOUN
bam-9161	17	168	of	of	ADP
bam-9161	17	169	vod	vod	NOUN
bam-9161	17	170	(	(	PUNCT
bam-9161	17	171	see	see	VERB
bam-9161	17	172	figure	figure	NOUN
bam-9161	17	173	1	1	NUM
bam-9161	17	174	for	for	ADP
bam-9161	17	175	details	detail	NOUN
bam-9161	17	176	of	of	ADP
bam-9161	17	177	the	the	DET
bam-9161	17	178	pathogenesis).5	pathogenesis).5	PROPN
bam-9161	17	179	diagnosis	diagnosis	NOUN
bam-9161	17	180	of	of	ADP
bam-9161	17	181	vod	vod	NOUN
bam-9161	17	182	is	be	AUX
bam-9161	17	183	based	base	VERB
bam-9161	17	184	on	on	ADP
bam-9161	17	185	clinical	clinical	ADJ
bam-9161	17	186	evidence	evidence	NOUN
bam-9161	17	187	and	and	CCONJ
bam-9161	17	188	examination	examination	NOUN
bam-9161	17	189	.	.	PUNCT
bam-9161	18	1	recently	recently	ADV
bam-9161	18	2	,	,	PUNCT
bam-9161	18	3	the	the	DET
bam-9161	18	4	european	european	ADJ
bam-9161	18	5	society	society	PROPN
bam-9161	18	6	for	for	ADP
bam-9161	18	7	blood	blood	NOUN
bam-9161	18	8	and	and	CCONJ
bam-9161	18	9	marrow	marrow	NOUN
bam-9161	18	10	transplantation	transplantation	NOUN
bam-9161	18	11	(	(	PUNCT
bam-9161	18	12	ebmt	ebmt	NOUN
bam-9161	18	13	)	)	PUNCT
bam-9161	18	14	has	have	AUX
bam-9161	18	15	provided	provide	VERB
bam-9161	18	16	a	a	DET
bam-9161	18	17	diagnostic	diagnostic	ADJ
bam-9161	18	18	guideline	guideline	NOUN
bam-9161	18	19	and	and	CCONJ
bam-9161	18	20	severity	severity	NOUN
bam-9161	18	21	grading	grade	VERB
bam-9161	18	22	criteria	criterion	NOUN
bam-9161	18	23	for	for	ADP
bam-9161	18	24	the	the	DET
bam-9161	18	25	disease	disease	NOUN
bam-9161	18	26	in	in	ADP
bam-9161	18	27	adults	adult	NOUN
bam-9161	18	28	and	and	CCONJ
bam-9161	18	29	children.2	children.2	PRON
bam-9161	18	30	if	if	SCONJ
bam-9161	18	31	two	two	NUM
bam-9161	18	32	or	or	CCONJ
bam-9161	18	33	more	more	ADJ
bam-9161	18	34	of	of	ADP
bam-9161	18	35	the	the	DET
bam-9161	18	36	following	follow	VERB
bam-9161	18	37	criteria	criterion	NOUN
bam-9161	18	38	are	be	AUX
bam-9161	18	39	present	present	ADJ
bam-9161	18	40	the	the	DET
bam-9161	18	41	diagnosis	diagnosis	NOUN
bam-9161	18	42	is	be	AUX
bam-9161	18	43	at	at	ADV
bam-9161	18	44	least	least	ADJ
bam-9161	18	45	higly	higly	ADV
bam-9161	18	46	suspected	suspect	VERB
bam-9161	18	47	:	:	PUNCT
bam-9161	18	48	•	•	NUM
bam-9161	18	49	unexplained	unexplained	ADJ
bam-9161	18	50	consumptive	consumptive	NOUN
bam-9161	18	51	and	and	CCONJ
bam-9161	18	52	transfusion	transfusion	NOUN
bam-9161	18	53	refractory	refractory	NOUN
bam-9161	18	54	thrombocytopenia	thrombocytopenia	PROPN
bam-9161	18	55	.	.	PUNCT
bam-9161	19	1	•	•	NUM
bam-9161	19	2	unexplained	unexplained	ADJ
bam-9161	19	3	weight	weight	NOUN
bam-9161	19	4	gain	gain	NOUN
bam-9161	19	5	in	in	ADP
bam-9161	19	6	three	three	NUM
bam-9161	19	7	consecutive	consecutive	ADJ
bam-9161	19	8	days	day	NOUN
bam-9161	19	9	,	,	PUNCT
bam-9161	19	10	despite	despite	SCONJ
bam-9161	19	11	the	the	DET
bam-9161	19	12	use	use	NOUN
bam-9161	19	13	of	of	ADP
bam-9161	19	14	diuretics	diuretic	NOUN
bam-9161	19	15	or	or	CCONJ
bam-9161	19	16	a	a	DET
bam-9161	19	17	weight	weight	NOUN
bam-9161	19	18	gain	gain	NOUN
bam-9161	19	19	45	45	NUM
bam-9161	19	20	%	%	NOUN
bam-9161	19	21	above	above	ADP
bam-9161	19	22	baseline	baseline	NOUN
bam-9161	19	23	value	value	NOUN
bam-9161	19	24	.	.	PUNCT
bam-9161	20	1	•	•	NUM
bam-9161	20	2	hepatomegaly	hepatomegaly	PROPN
bam-9161	20	3	above	above	ADP
bam-9161	20	4	baseline	baseline	NOUN
bam-9161	20	5	value	value	NOUN
bam-9161	20	6	.	.	PUNCT
bam-9161	21	1	•	•	NUM
bam-9161	21	2	ascites	ascite	NOUN
bam-9161	21	3	above	above	ADP
bam-9161	21	4	baseline	baseline	NOUN
bam-9161	21	5	value	value	NOUN
bam-9161	21	6	.	.	PUNCT
bam-9161	22	1	•	•	NUM
bam-9161	22	2	bilirubin	bilirubin	NOUN
bam-9161	22	3	rise	rise	NOUN
bam-9161	22	4	from	from	ADP
bam-9161	22	5	baseline	baseline	NOUN
bam-9161	22	6	on	on	ADP
bam-9161	22	7	three	three	NUM
bam-9161	22	8	consecutive	consecutive	ADJ
bam-9161	22	9	days	day	NOUN
bam-9161	22	10	or	or	CCONJ
bam-9161	22	11	bilirubin	bilirubin	NOUN
bam-9161	22	12	≥	≥	NOUN
bam-9161	22	13	2	2	NUM
bam-9161	22	14	mg	mg	PROPN
bam-9161	22	15	/	/	SYM
bam-9161	22	16	dl	dl	PROPN
bam-9161	22	17	within	within	ADP
bam-9161	22	18	72	72	NUM
bam-9161	22	19	hrs	hrs	NOUN
bam-9161	22	20	.	.	PUNCT
bam-9161	23	1	severe	severe	ADJ
bam-9161	23	2	veno	veno	NOUN
bam-9161	23	3	-	-	PUNCT
bam-9161	23	4	occlusive	occlusive	PROPN
bam-9161	23	5	disease	disease	NOUN
bam-9161	23	6	eur	eur	PROPN
bam-9161	23	7	j	j	PROPN
bam-9161	23	8	transl	transl	PROPN
bam-9161	23	9	myol	myol	NOUN
bam-9161	23	10	2020	2020	NUM
bam-9161	23	11	;	;	PUNCT
bam-9161	23	12	30	30	NUM
bam-9161	23	13	(	(	PUNCT
bam-9161	23	14	3	3	NUM
bam-9161	23	15	):	):	PUNCT
bam-9161	23	16	9161	9161	NUM
bam-9161	23	17	.	.	PUNCT
bam-9161	24	1	doi	doi	NOUN
bam-9161	24	2	:	:	PUNCT
bam-9161	24	3	10.4081	10.4081	NUM
bam-9161	24	4	/	/	SYM
bam-9161	24	5	ejtm.2020.9161	ejtm.2020.9161	ADJ
bam-9161	24	6	2	2	NUM
bam-9161	24	7	these	these	DET
bam-9161	24	8	new	new	ADJ
bam-9161	24	9	diagnostic	diagnostic	ADJ
bam-9161	24	10	guidelines	guideline	NOUN
bam-9161	24	11	provide	provide	VERB
bam-9161	24	12	the	the	DET
bam-9161	24	13	criteria	criterion	NOUN
bam-9161	24	14	for	for	ADP
bam-9161	24	15	early	early	ADJ
bam-9161	24	16	diagnosis	diagnosis	NOUN
bam-9161	24	17	and	and	CCONJ
bam-9161	24	18	treatment	treatment	NOUN
bam-9161	24	19	of	of	ADP
bam-9161	24	20	the	the	DET
bam-9161	24	21	disease	disease	NOUN
bam-9161	24	22	.	.	PUNCT
bam-9161	25	1	when	when	SCONJ
bam-9161	25	2	clinical	clinical	ADJ
bam-9161	25	3	criteria	criterion	NOUN
bam-9161	25	4	are	be	AUX
bam-9161	25	5	not	not	PART
bam-9161	25	6	sufficient	sufficient	ADJ
bam-9161	25	7	to	to	ADP
bam-9161	25	8	a	a	DET
bam-9161	25	9	diagnose	diagnose	NOUN
bam-9161	25	10	a	a	DET
bam-9161	25	11	vod	vod	NOUN
bam-9161	25	12	,	,	PUNCT
bam-9161	25	13	but	but	CCONJ
bam-9161	25	14	the	the	DET
bam-9161	25	15	suspicion	suspicion	NOUN
bam-9161	25	16	is	be	AUX
bam-9161	25	17	high	high	ADJ
bam-9161	25	18	,	,	PUNCT
bam-9161	25	19	a	a	DET
bam-9161	25	20	liver	liver	NOUN
bam-9161	25	21	biopsy	biopsy	NOUN
bam-9161	25	22	may	may	AUX
bam-9161	25	23	be	be	AUX
bam-9161	25	24	used	use	VERB
bam-9161	25	25	to	to	PART
bam-9161	25	26	confirm	confirm	VERB
bam-9161	25	27	or	or	CCONJ
bam-9161	25	28	not	not	PART
bam-9161	25	29	the	the	DET
bam-9161	25	30	diagnosis.6	diagnosis.6	PROPN
bam-9161	25	31	in	in	ADP
bam-9161	25	32	patients	patient	NOUN
bam-9161	25	33	over	over	ADP
bam-9161	25	34	one	one	NUM
bam-9161	25	35	-	-	PUNCT
bam-9161	25	36	month	month	NOUN
bam-9161	25	37	of	of	ADP
bam-9161	25	38	age	age	NOUN
bam-9161	25	39	defibrotide	defibrotide	NOUN
bam-9161	25	40	has	have	AUX
bam-9161	25	41	been	be	AUX
bam-9161	25	42	approved	approve	VERB
bam-9161	25	43	to	to	PART
bam-9161	25	44	treat	treat	VERB
bam-9161	25	45	this	this	DET
bam-9161	25	46	condition	condition	NOUN
bam-9161	25	47	in	in	ADP
bam-9161	25	48	the	the	DET
bam-9161	25	49	united	united	PROPN
bam-9161	25	50	states	states	PROPN
bam-9161	25	51	and	and	CCONJ
bam-9161	25	52	the	the	DET
bam-9161	25	53	european	european	ADJ
bam-9161	25	54	union.1	union.1	ADJ
bam-9161	25	55	defibrotide	defibrotide	NOUN
bam-9161	25	56	is	be	AUX
bam-9161	25	57	a	a	DET
bam-9161	25	58	polydeoxyribonucleotide	polydeoxyribonucleotide	NOUN
bam-9161	25	59	that	that	PRON
bam-9161	25	60	has	have	VERB
bam-9161	25	61	antiinflammatory	antiinflammatory	NOUN
bam-9161	25	62	effects	effect	NOUN
bam-9161	25	63	that	that	PRON
bam-9161	25	64	protects	protect	VERB
bam-9161	25	65	endothelial	endothelial	ADJ
bam-9161	25	66	cells	cell	NOUN
bam-9161	25	67	,	,	PUNCT
bam-9161	25	68	thus	thus	ADV
bam-9161	25	69	helping	help	VERB
bam-9161	25	70	to	to	PART
bam-9161	25	71	restore	restore	VERB
bam-9161	25	72	thrombo	thrombo	ADJ
bam-9161	25	73	-	-	PUNCT
bam-9161	25	74	fibrinolytic	fibrinolytic	ADJ
bam-9161	25	75	balance.7	balance.7	PROPN
bam-9161	25	76	therefore	therefore	ADV
bam-9161	25	77	,	,	PUNCT
bam-9161	25	78	the	the	DET
bam-9161	25	79	aim	aim	NOUN
bam-9161	25	80	of	of	ADP
bam-9161	25	81	this	this	DET
bam-9161	25	82	report	report	NOUN
bam-9161	25	83	was	be	AUX
bam-9161	25	84	to	to	ADP
bam-9161	25	85	the	the	DET
bam-9161	25	86	present	present	NOUN
bam-9161	25	87	in	in	ADP
bam-9161	25	88	a	a	DET
bam-9161	25	89	14	14	NUM
bam-9161	25	90	-	-	PUNCT
bam-9161	25	91	month	month	NOUN
bam-9161	25	92	-	-	PUNCT
bam-9161	25	93	old	old	ADJ
bam-9161	25	94	girl	girl	NOUN
bam-9161	25	95	a	a	DET
bam-9161	25	96	case	case	NOUN
bam-9161	25	97	of	of	ADP
bam-9161	25	98	sever	sever	VERB
bam-9161	25	99	vod	vod	NOUN
bam-9161	25	100	after	after	ADP
bam-9161	25	101	autologous	autologous	ADJ
bam-9161	25	102	stem	stem	NOUN
bam-9161	25	103	cell	cell	NOUN
bam-9161	25	104	transplantation	transplantation	NOUN
bam-9161	25	105	that	that	PRON
bam-9161	25	106	was	be	AUX
bam-9161	25	107	successfully	successfully	ADV
bam-9161	25	108	treated	treat	VERB
bam-9161	25	109	with	with	ADP
bam-9161	25	110	defibrotide	defibrotide	NOUN
bam-9161	25	111	.	.	PUNCT
bam-9161	26	1	case	case	NOUN
bam-9161	26	2	presentation	presentation	NOUN
bam-9161	26	3	a	a	DET
bam-9161	26	4	14	14	NUM
bam-9161	26	5	-	-	PUNCT
bam-9161	26	6	month	month	NOUN
bam-9161	26	7	-	-	PUNCT
bam-9161	26	8	old	old	ADJ
bam-9161	26	9	girl	girl	NOUN
bam-9161	26	10	,	,	PUNCT
bam-9161	26	11	who	who	PRON
bam-9161	26	12	had	have	VERB
bam-9161	26	13	neuroblastoma	neuroblastoma	NOUN
bam-9161	26	14	with	with	ADP
bam-9161	26	15	bone	bone	NOUN
bam-9161	26	16	metastasis	metastasis	NOUN
bam-9161	26	17	,	,	PUNCT
bam-9161	26	18	had	have	AUX
bam-9161	26	19	been	be	AUX
bam-9161	26	20	treated	treat	VERB
bam-9161	26	21	with	with	ADP
bam-9161	26	22	neoadjuvant	neoadjuvant	ADJ
bam-9161	26	23	chemotherapy	chemotherapy	NOUN
bam-9161	26	24	with	with	ADP
bam-9161	26	25	the	the	DET
bam-9161	26	26	vincristine	vincristine	NOUN
bam-9161	26	27	,	,	PUNCT
bam-9161	26	28	prednisolone	prednisolone	PROPN
bam-9161	26	29	,	,	PUNCT
bam-9161	26	30	etoposide	etoposide	NOUN
bam-9161	26	31	and	and	CCONJ
bam-9161	26	32	chlorambucil	chlorambucil	PROPN
bam-9161	26	33	(	(	PUNCT
bam-9161	26	34	opec	opec	PROPN
bam-9161	26	35	)	)	PUNCT
bam-9161	26	36	protocol	protocol	NOUN
bam-9161	26	37	for	for	ADP
bam-9161	26	38	two	two	NUM
bam-9161	26	39	courses	course	NOUN
bam-9161	26	40	.	.	PUNCT
bam-9161	27	1	she	she	PRON
bam-9161	27	2	then	then	ADV
bam-9161	27	3	underwent	undergo	VERB
bam-9161	27	4	complete	complete	ADJ
bam-9161	27	5	excision	excision	NOUN
bam-9161	27	6	of	of	ADP
bam-9161	27	7	an	an	DET
bam-9161	27	8	abdominal	abdominal	ADJ
bam-9161	27	9	mass	mass	NOUN
bam-9161	27	10	and	and	CCONJ
bam-9161	27	11	left	leave	VERB
bam-9161	27	12	kidney	kidney	NOUN
bam-9161	27	13	surgery	surgery	NOUN
bam-9161	27	14	.	.	PUNCT
bam-9161	28	1	then	then	ADV
bam-9161	28	2	chemotherapy	chemotherapy	NOUN
bam-9161	28	3	followed	follow	VERB
bam-9161	28	4	(	(	PUNCT
bam-9161	28	5	topotecan	topotecan	ADJ
bam-9161	28	6	/	/	SYM
bam-9161	28	7	endoxan	endoxan	NOUN
bam-9161	28	8	)	)	PUNCT
bam-9161	28	9	for	for	ADP
bam-9161	28	10	5	5	NUM
bam-9161	28	11	cycles	cycle	NOUN
bam-9161	28	12	.	.	PUNCT
bam-9161	29	1	because	because	SCONJ
bam-9161	29	2	iodine-131	iodine-131	NOUN
bam-9161	29	3	-	-	PUNCT
bam-9161	29	4	meta	meta	NOUN
bam-9161	29	5	-	-	PUNCT
bam-9161	29	6	iodobenzylguanidine	iodobenzylguanidine	ADJ
bam-9161	29	7	(	(	PUNCT
bam-9161	29	8	mibg	mibg	PROPN
bam-9161	29	9	)	)	PUNCT
bam-9161	29	10	was	be	AUX
bam-9161	29	11	normal	normal	ADJ
bam-9161	29	12	,	,	PUNCT
bam-9161	29	13	she	she	PRON
bam-9161	29	14	was	be	AUX
bam-9161	29	15	candidate	candidate	NOUN
bam-9161	29	16	for	for	ADP
bam-9161	29	17	haematopoietic	haematopoietic	ADJ
bam-9161	29	18	stem	stem	NOUN
bam-9161	29	19	cell	cell	NOUN
bam-9161	29	20	transplantation	transplantation	NOUN
bam-9161	29	21	(	(	PUNCT
bam-9161	29	22	hsct	hsct	PROPN
bam-9161	29	23	)	)	PUNCT
bam-9161	29	24	at	at	ADP
bam-9161	29	25	the	the	DET
bam-9161	29	26	age	age	NOUN
bam-9161	29	27	of	of	ADP
bam-9161	29	28	24	24	NUM
bam-9161	29	29	months	month	NOUN
bam-9161	29	30	.	.	PUNCT
bam-9161	30	1	in	in	ADP
bam-9161	30	2	2017	2017	NUM
bam-9161	30	3	,	,	PUNCT
bam-9161	30	4	she	she	PRON
bam-9161	30	5	underwent	undergo	VERB
bam-9161	30	6	autologous	autologous	ADJ
bam-9161	30	7	stem	stem	NOUN
bam-9161	30	8	cell	cell	NOUN
bam-9161	30	9	transplantation	transplantation	NOUN
bam-9161	30	10	.	.	PUNCT
bam-9161	31	1	having	have	VERB
bam-9161	31	2	good	good	ADJ
bam-9161	31	3	conditions	condition	NOUN
bam-9161	31	4	,	,	PUNCT
bam-9161	31	5	she	she	PRON
bam-9161	31	6	was	be	AUX
bam-9161	31	7	discharged	discharge	VERB
bam-9161	31	8	on	on	ADP
bam-9161	31	9	day	day	NOUN
bam-9161	31	10	13	13	NUM
bam-9161	31	11	.	.	PUNCT
bam-9161	32	1	on	on	ADP
bam-9161	32	2	day	day	NOUN
bam-9161	32	3	28	28	NUM
bam-9161	32	4	,	,	PUNCT
bam-9161	32	5	the	the	DET
bam-9161	32	6	patient	patient	NOUN
bam-9161	32	7	returned	return	VERB
bam-9161	32	8	to	to	ADP
bam-9161	32	9	hospital	hospital	NOUN
bam-9161	32	10	with	with	ADP
bam-9161	32	11	symptoms	symptom	NOUN
bam-9161	32	12	of	of	ADP
bam-9161	32	13	abdominal	abdominal	ADJ
bam-9161	32	14	distention	distention	NOUN
bam-9161	32	15	(	(	PUNCT
bam-9161	32	16	figure	figure	NOUN
bam-9161	32	17	2	2	NUM
bam-9161	32	18	)	)	PUNCT
bam-9161	32	19	and	and	CCONJ
bam-9161	32	20	pain	pain	NOUN
bam-9161	32	21	,	,	PUNCT
bam-9161	32	22	malaise	malaise	NOUN
bam-9161	32	23	,	,	PUNCT
bam-9161	32	24	fever	fever	NOUN
bam-9161	32	25	,	,	PUNCT
bam-9161	32	26	weight	weight	NOUN
bam-9161	32	27	gain	gain	NOUN
bam-9161	32	28	,	,	PUNCT
bam-9161	32	29	vomiting	vomiting	NOUN
bam-9161	32	30	and	and	CCONJ
bam-9161	32	31	low	low	ADJ
bam-9161	32	32	urine	urine	NOUN
bam-9161	32	33	output	output	NOUN
bam-9161	32	34	.	.	PUNCT
bam-9161	33	1	during	during	ADP
bam-9161	33	2	the	the	DET
bam-9161	33	3	examination	examination	NOUN
bam-9161	33	4	,	,	PUNCT
bam-9161	33	5	she	she	PRON
bam-9161	33	6	had	have	VERB
bam-9161	33	7	abdominal	abdominal	ADJ
bam-9161	33	8	ascites	ascite	NOUN
bam-9161	33	9	and	and	CCONJ
bam-9161	33	10	tender	tender	ADJ
bam-9161	33	11	hepatomegaly	hepatomegaly	NOUN
bam-9161	33	12	.	.	PUNCT
bam-9161	34	1	she	she	PRON
bam-9161	34	2	was	be	AUX
bam-9161	34	3	admitted	admit	VERB
bam-9161	34	4	to	to	ADP
bam-9161	34	5	the	the	DET
bam-9161	34	6	hospital	hospital	NOUN
bam-9161	34	7	with	with	ADP
bam-9161	34	8	a	a	DET
bam-9161	34	9	possible	possible	ADJ
bam-9161	34	10	diagnosis	diagnosis	NOUN
bam-9161	34	11	of	of	ADP
bam-9161	34	12	vod	vod	NOUN
bam-9161	34	13	.	.	PUNCT
bam-9161	35	1	laboratory	laboratory	NOUN
bam-9161	35	2	studies	study	NOUN
bam-9161	35	3	indicated	indicate	VERB
bam-9161	35	4	that	that	SCONJ
bam-9161	35	5	she	she	PRON
bam-9161	35	6	had	have	VERB
bam-9161	35	7	high	high	ADJ
bam-9161	35	8	serum	serum	NOUN
bam-9161	35	9	aminotransferases	aminotransferase	NOUN
bam-9161	35	10	,	,	PUNCT
bam-9161	35	11	bilirubin	bilirubin	NOUN
bam-9161	35	12	and	and	CCONJ
bam-9161	35	13	thrombocytopenia	thrombocytopenia	PROPN
bam-9161	35	14	(	(	PUNCT
bam-9161	35	15	figure	figure	NOUN
bam-9161	35	16	3	3	NUM
bam-9161	35	17	)	)	PUNCT
bam-9161	35	18	.	.	PUNCT
bam-9161	36	1	abdominal	abdominal	ADJ
bam-9161	36	2	sonography	sonography	NOUN
bam-9161	36	3	showed	show	VERB
bam-9161	36	4	marked	mark	VERB
bam-9161	36	5	hepatomegaly	hepatomegaly	NOUN
bam-9161	36	6	and	and	CCONJ
bam-9161	36	7	mild	mild	ADJ
bam-9161	36	8	to	to	ADP
bam-9161	36	9	moderate	moderate	ADJ
bam-9161	36	10	ascites	ascite	NOUN
bam-9161	36	11	.	.	PUNCT
bam-9161	37	1	serologic	serologic	VERB
bam-9161	37	2	analyses	analysis	NOUN
bam-9161	37	3	for	for	ADP
bam-9161	37	4	hepatitis	hepatitis	NOUN
bam-9161	37	5	and	and	CCONJ
bam-9161	37	6	cytomegalovirus	cytomegalovirus	NOUN
bam-9161	37	7	(	(	PUNCT
bam-9161	37	8	cmv	cmv	PROPN
bam-9161	37	9	)	)	PUNCT
bam-9161	37	10	yielded	yield	VERB
bam-9161	37	11	negative	negative	ADJ
bam-9161	37	12	results	result	NOUN
bam-9161	37	13	.	.	PUNCT
bam-9161	38	1	during	during	ADP
bam-9161	38	2	hospitalization	hospitalization	NOUN
bam-9161	38	3	on	on	ADP
bam-9161	38	4	day	day	NOUN
bam-9161	38	5	29	29	NUM
bam-9161	38	6	,	,	PUNCT
bam-9161	38	7	the	the	DET
bam-9161	38	8	patient	patient	NOUN
bam-9161	38	9	developed	develop	VERB
bam-9161	38	10	respiratory	respiratory	ADJ
bam-9161	38	11	distress	distress	NOUN
bam-9161	38	12	,	,	PUNCT
bam-9161	38	13	low	low	ADJ
bam-9161	38	14	oxygen	oxygen	NOUN
bam-9161	38	15	saturation	saturation	NOUN
bam-9161	38	16	,	,	PUNCT
bam-9161	38	17	tachypnea	tachypnea	NOUN
bam-9161	38	18	,	,	PUNCT
bam-9161	38	19	fig	fig	NOUN
bam-9161	38	20	1	1	NUM
bam-9161	38	21	.	.	PUNCT
bam-9161	39	1	pathogenesis	pathogenesis	NOUN
bam-9161	39	2	of	of	ADP
bam-9161	39	3	vod	vod	PROPN
bam-9161	39	4	fig	fig	PROPN
bam-9161	39	5	2	2	NUM
bam-9161	39	6	.	.	PUNCT
bam-9161	40	1	ascitic	ascitic	ADJ
bam-9161	40	2	distention	distention	NOUN
bam-9161	40	3	of	of	ADP
bam-9161	40	4	patient	patient	NOUN
bam-9161	40	5	’s	’s	PART
bam-9161	40	6	abdomen	abdoman	NOUN
bam-9161	40	7	severe	severe	ADJ
bam-9161	40	8	veno	veno	NOUN
bam-9161	40	9	-	-	PUNCT
bam-9161	40	10	occlusive	occlusive	PROPN
bam-9161	40	11	disease	disease	NOUN
bam-9161	40	12	eur	eur	PROPN
bam-9161	40	13	j	j	PROPN
bam-9161	40	14	transl	transl	PROPN
bam-9161	40	15	myol	myol	NOUN
bam-9161	40	16	2020	2020	NUM
bam-9161	40	17	;	;	PUNCT
bam-9161	40	18	30	30	NUM
bam-9161	40	19	(	(	PUNCT
bam-9161	40	20	3	3	NUM
bam-9161	40	21	):	):	PUNCT
bam-9161	40	22	9161	9161	NUM
bam-9161	40	23	.	.	PUNCT
bam-9161	41	1	doi	doi	NOUN
bam-9161	41	2	:	:	PUNCT
bam-9161	41	3	10.4081	10.4081	NUM
bam-9161	41	4	/	/	SYM
bam-9161	41	5	ejtm.2020.9161	ejtm.2020.9161	ADJ
bam-9161	41	6	3	3	NUM
bam-9161	41	7	and	and	CCONJ
bam-9161	41	8	tachycardia	tachycardia	NOUN
bam-9161	41	9	.	.	PUNCT
bam-9161	42	1	she	she	PRON
bam-9161	42	2	was	be	AUX
bam-9161	42	3	transferred	transfer	VERB
bam-9161	42	4	to	to	ADP
bam-9161	42	5	the	the	DET
bam-9161	42	6	intensive	intensive	ADJ
bam-9161	42	7	care	care	NOUN
bam-9161	42	8	unit	unit	NOUN
bam-9161	42	9	.	.	PUNCT
bam-9161	43	1	she	she	PRON
bam-9161	43	2	was	be	AUX
bam-9161	43	3	treated	treat	VERB
bam-9161	43	4	with	with	ADP
bam-9161	43	5	antibiotics	antibiotic	NOUN
bam-9161	43	6	,	,	PUNCT
bam-9161	43	7	heparin	heparin	NOUN
bam-9161	43	8	,	,	PUNCT
bam-9161	43	9	nacetylcysteine	nacetylcysteine	ADJ
bam-9161	43	10	,	,	PUNCT
bam-9161	43	11	low	low	ADJ
bam-9161	43	12	dose	dose	NOUN
bam-9161	43	13	dopamine	dopamine	NOUN
bam-9161	43	14	,	,	PUNCT
bam-9161	43	15	albumin	albumin	NOUN
bam-9161	43	16	and	and	CCONJ
bam-9161	43	17	a	a	DET
bam-9161	43	18	diuretic	diuretic	NOUN
bam-9161	43	19	.	.	PUNCT
bam-9161	44	1	according	accord	VERB
bam-9161	44	2	to	to	ADP
bam-9161	44	3	serial	serial	ADJ
bam-9161	44	4	laboratory	laboratory	NOUN
bam-9161	44	5	tests	test	NOUN
bam-9161	44	6	,	,	PUNCT
bam-9161	44	7	the	the	DET
bam-9161	44	8	patient	patient	NOUN
bam-9161	44	9	's	's	PART
bam-9161	44	10	bilirubin	bilirubin	NOUN
bam-9161	44	11	was	be	AUX
bam-9161	44	12	rising	rise	VERB
bam-9161	44	13	.	.	PUNCT
bam-9161	45	1	on	on	ADP
bam-9161	45	2	day	day	NOUN
bam-9161	45	3	31	31	NUM
bam-9161	45	4	,	,	PUNCT
bam-9161	45	5	because	because	SCONJ
bam-9161	45	6	of	of	ADP
bam-9161	45	7	the	the	DET
bam-9161	45	8	severe	severe	ADJ
bam-9161	45	9	vod	vod	NOUN
bam-9161	45	10	,	,	PUNCT
bam-9161	45	11	treatment	treatment	NOUN
bam-9161	45	12	with	with	ADP
bam-9161	45	13	defibrotide	defibrotide	NOUN
bam-9161	45	14	(	(	PUNCT
bam-9161	45	15	25mg	25mg	NOUN
bam-9161	45	16	/	/	SYM
bam-9161	45	17	kg	kg	ADJ
bam-9161	45	18	/	/	SYM
bam-9161	45	19	day	day	NOUN
bam-9161	45	20	)	)	PUNCT
bam-9161	45	21	was	be	AUX
bam-9161	45	22	commenced	commence	VERB
bam-9161	45	23	.	.	PUNCT
bam-9161	46	1	defibrotide	defibrotide	NOUN
bam-9161	46	2	treatment	treatment	NOUN
bam-9161	46	3	for	for	ADP
bam-9161	46	4	21	21	NUM
bam-9161	46	5	days	day	NOUN
bam-9161	46	6	was	be	AUX
bam-9161	46	7	administered	administer	VERB
bam-9161	46	8	.	.	PUNCT
bam-9161	47	1	she	she	PRON
bam-9161	47	2	responded	respond	VERB
bam-9161	47	3	well	well	ADV
bam-9161	47	4	to	to	ADP
bam-9161	47	5	treatment	treatment	NOUN
bam-9161	47	6	and	and	CCONJ
bam-9161	47	7	was	be	AUX
bam-9161	47	8	discharged	discharge	VERB
bam-9161	47	9	in	in	ADP
bam-9161	47	10	a	a	DET
bam-9161	47	11	good	good	ADJ
bam-9161	47	12	general	general	ADJ
bam-9161	47	13	condition	condition	NOUN
bam-9161	47	14	.	.	PUNCT
bam-9161	48	1	discussion	discussion	NOUN
bam-9161	48	2	sos	sos	PROPN
bam-9161	48	3	/	/	SYM
bam-9161	48	4	vod	vod	NOUN
bam-9161	48	5	is	be	AUX
bam-9161	48	6	one	one	NUM
bam-9161	48	7	of	of	ADP
bam-9161	48	8	the	the	DET
bam-9161	48	9	most	most	ADV
bam-9161	48	10	dangerous	dangerous	ADJ
bam-9161	48	11	complications	complication	NOUN
bam-9161	48	12	after	after	ADP
bam-9161	48	13	hsct.3,5,6	hsct.3,5,6	NOUN
bam-9161	48	14	recognition	recognition	NOUN
bam-9161	48	15	of	of	ADP
bam-9161	48	16	this	this	DET
bam-9161	48	17	disease	disease	NOUN
bam-9161	48	18	and	and	CCONJ
bam-9161	48	19	its	its	PRON
bam-9161	48	20	predisposing	predispose	VERB
bam-9161	48	21	factors	factor	NOUN
bam-9161	48	22	is	be	AUX
bam-9161	48	23	important	important	ADJ
bam-9161	48	24	for	for	ADP
bam-9161	48	25	early	early	ADJ
bam-9161	48	26	diagnosis	diagnosis	NOUN
bam-9161	48	27	and	and	CCONJ
bam-9161	48	28	treatment.3,5,6	treatment.3,5,6	NOUN
bam-9161	48	29	therefore	therefore	ADV
bam-9161	48	30	,	,	PUNCT
bam-9161	48	31	having	have	VERB
bam-9161	48	32	diagnostic	diagnostic	ADJ
bam-9161	48	33	criteria	criterion	NOUN
bam-9161	48	34	would	would	AUX
bam-9161	48	35	be	be	AUX
bam-9161	48	36	helpful	helpful	ADJ
bam-9161	48	37	in	in	ADP
bam-9161	48	38	patient	patient	ADJ
bam-9161	48	39	management	management	NOUN
bam-9161	48	40	.	.	PUNCT
bam-9161	49	1	the	the	DET
bam-9161	49	2	ebmt	ebmt	NOUN
bam-9161	49	3	group	group	NOUN
bam-9161	49	4	has	have	AUX
bam-9161	49	5	provided	provide	VERB
bam-9161	49	6	diagnostic	diagnostic	ADJ
bam-9161	49	7	criteria	criterion	NOUN
bam-9161	49	8	and	and	CCONJ
bam-9161	49	9	divides	divide	VERB
bam-9161	49	10	the	the	DET
bam-9161	49	11	risk	risk	NOUN
bam-9161	49	12	factors	factor	NOUN
bam-9161	49	13	into	into	ADP
bam-9161	49	14	several	several	ADJ
bam-9161	49	15	groups	group	NOUN
bam-9161	49	16	,	,	PUNCT
bam-9161	49	17	including	include	VERB
bam-9161	49	18	:	:	PUNCT
bam-9161	49	19	transplant	transplant	NOUN
bam-9161	49	20	,	,	PUNCT
bam-9161	49	21	hepatic	hepatic	NOUN
bam-9161	49	22	,	,	PUNCT
bam-9161	49	23	patient	patient	ADJ
bam-9161	49	24	and	and	CCONJ
bam-9161	49	25	disease	disease	NOUN
bam-9161	49	26	-	-	PUNCT
bam-9161	49	27	related	relate	VERB
bam-9161	49	28	.	.	PUNCT
bam-9161	50	1	these	these	DET
bam-9161	50	2	diagnostic	diagnostic	ADJ
bam-9161	50	3	criteria	criterion	NOUN
bam-9161	50	4	were	be	AUX
bam-9161	50	5	used	use	VERB
bam-9161	50	6	in	in	ADP
bam-9161	50	7	the	the	DET
bam-9161	50	8	diagnosis	diagnosis	NOUN
bam-9161	50	9	of	of	ADP
bam-9161	50	10	our	our	PRON
bam-9161	50	11	patient	patient	NOUN
bam-9161	50	12	.	.	PUNCT
bam-9161	51	1	she	she	PRON
bam-9161	51	2	had	have	VERB
bam-9161	51	3	five	five	NUM
bam-9161	51	4	criteria	criterion	NOUN
bam-9161	51	5	,	,	PUNCT
bam-9161	51	6	which	which	PRON
bam-9161	51	7	were	be	AUX
bam-9161	51	8	:	:	PUNCT
bam-9161	51	9	hepatomegaly	hepatomegaly	PROPN
bam-9161	51	10	confirmed	confirm	VERB
bam-9161	51	11	by	by	ADP
bam-9161	51	12	imaging	imaging	NOUN
bam-9161	51	13	,	,	PUNCT
bam-9161	51	14	ascites	ascite	NOUN
bam-9161	51	15	,	,	PUNCT
bam-9161	51	16	weight	weight	NOUN
bam-9161	51	17	gain	gain	NOUN
bam-9161	51	18	,	,	PUNCT
bam-9161	51	19	increase	increase	VERB
bam-9161	51	20	bilirubin	bilirubin	NOUN
bam-9161	51	21	and	and	CCONJ
bam-9161	51	22	thrombocytopenia	thrombocytopenia	PROPN
bam-9161	51	23	.	.	PUNCT
bam-9161	52	1	multi	multi	ADJ
bam-9161	52	2	-	-	ADJ
bam-9161	52	3	organ	organ	ADJ
bam-9161	52	4	dysfunction	dysfunction	NOUN
bam-9161	52	5	(	(	PUNCT
bam-9161	52	6	mod	mod	PROPN
bam-9161	52	7	)	)	PUNCT
bam-9161	52	8	in	in	ADP
bam-9161	52	9	vod	vod	NOUN
bam-9161	52	10	is	be	AUX
bam-9161	52	11	most	most	ADV
bam-9161	52	12	considered	consider	VERB
bam-9161	52	13	when	when	SCONJ
bam-9161	52	14	associated	associate	VERB
bam-9161	52	15	with	with	ADP
bam-9161	52	16	renal	renal	ADJ
bam-9161	52	17	and/or	and/or	CCONJ
bam-9161	52	18	pulmonary	pulmonary	ADJ
bam-9161	52	19	dysfunction	dysfunction	NOUN
bam-9161	52	20	.	.	PUNCT
bam-9161	53	1	its	its	PRON
bam-9161	53	2	survival	survival	NOUN
bam-9161	53	3	rate	rate	NOUN
bam-9161	53	4	is	be	AUX
bam-9161	53	5	20	20	NUM
bam-9161	53	6	-	-	SYM
bam-9161	53	7	30	30	NUM
bam-9161	53	8	%	%	NOUN
bam-9161	53	9	in	in	ADP
bam-9161	53	10	hsct	hsct	NOUN
bam-9161	53	11	patients	patient	NOUN
bam-9161	53	12	receiving	receive	VERB
bam-9161	53	13	supportive	supportive	ADJ
bam-9161	53	14	care	care	NOUN
bam-9161	53	15	alone.1,8	alone.1,8	ADJ
bam-9161	53	16	reports	report	NOUN
bam-9161	53	17	of	of	ADP
bam-9161	53	18	defibrotide	defibrotide	NOUN
bam-9161	53	19	for	for	ADP
bam-9161	53	20	both	both	CCONJ
bam-9161	53	21	the	the	DET
bam-9161	53	22	prophylaxis	prophylaxis	NOUN
bam-9161	53	23	and	and	CCONJ
bam-9161	53	24	treatment	treatment	NOUN
bam-9161	53	25	of	of	ADP
bam-9161	53	26	vod	vod	NOUN
bam-9161	53	27	suggest	suggest	VERB
bam-9161	53	28	that	that	SCONJ
bam-9161	53	29	this	this	DET
bam-9161	53	30	drug	drug	NOUN
bam-9161	53	31	may	may	AUX
bam-9161	53	32	have	have	VERB
bam-9161	53	33	a	a	DET
bam-9161	53	34	role	role	NOUN
bam-9161	53	35	in	in	ADP
bam-9161	53	36	reducing	reduce	VERB
bam-9161	53	37	the	the	DET
bam-9161	53	38	incidence	incidence	NOUN
bam-9161	53	39	and	and	CCONJ
bam-9161	53	40	mortality	mortality	NOUN
bam-9161	53	41	of	of	ADP
bam-9161	53	42	this	this	DET
bam-9161	53	43	complication	complication	NOUN
bam-9161	53	44	.	.	PUNCT
bam-9161	54	1	a	a	DET
bam-9161	54	2	systematic	systematic	ADJ
bam-9161	54	3	review	review	NOUN
bam-9161	54	4	study	study	NOUN
bam-9161	54	5	was	be	AUX
bam-9161	54	6	conducted	conduct	VERB
bam-9161	54	7	in	in	ADP
bam-9161	54	8	2017	2017	NUM
bam-9161	54	9	by	by	ADP
bam-9161	54	10	richardson	richardson	PROPN
bam-9161	54	11	and	and	CCONJ
bam-9161	54	12	colleagues	colleague	NOUN
bam-9161	54	13	,	,	PUNCT
bam-9161	54	14	on	on	ADP
bam-9161	54	15	the	the	DET
bam-9161	54	16	treatment	treatment	NOUN
bam-9161	54	17	of	of	ADP
bam-9161	54	18	vod	vod	NOUN
bam-9161	54	19	with	with	ADP
bam-9161	54	20	defibrotide.1	defibrotide.1	ADV
bam-9161	54	21	they	they	PRON
bam-9161	54	22	analyzed	analyze	VERB
bam-9161	54	23	17	17	NUM
bam-9161	54	24	studies	study	NOUN
bam-9161	54	25	with	with	ADP
bam-9161	54	26	2598	2598	NUM
bam-9161	54	27	patients	patient	NOUN
bam-9161	54	28	and	and	CCONJ
bam-9161	54	29	investigated	investigate	VERB
bam-9161	54	30	survival	survival	NOUN
bam-9161	54	31	of	of	ADP
bam-9161	54	32	patients	patient	NOUN
bam-9161	54	33	on	on	ADP
bam-9161	54	34	day	day	NOUN
bam-9161	54	35	100	100	NUM
bam-9161	54	36	after	after	ADP
bam-9161	54	37	transplantation	transplantation	NOUN
bam-9161	54	38	.	.	PUNCT
bam-9161	55	1	the	the	DET
bam-9161	55	2	results	result	NOUN
bam-9161	55	3	of	of	ADP
bam-9161	55	4	the	the	DET
bam-9161	55	5	study	study	NOUN
bam-9161	55	6	were	be	AUX
bam-9161	55	7	as	as	SCONJ
bam-9161	55	8	follows	follow	VERB
bam-9161	55	9	.	.	PUNCT
bam-9161	56	1	the	the	DET
bam-9161	56	2	pooled	pooled	ADJ
bam-9161	56	3	survival	survival	NOUN
bam-9161	56	4	rate	rate	NOUN
bam-9161	56	5	at	at	ADP
bam-9161	56	6	day	day	NOUN
bam-9161	56	7	100	100	NUM
bam-9161	56	8	was	be	AUX
bam-9161	56	9	54	54	NUM
bam-9161	56	10	%	%	NOUN
bam-9161	56	11	.	.	PUNCT
bam-9161	57	1	use	use	NOUN
bam-9161	57	2	of	of	ADP
bam-9161	57	3	defibrotide	defibrotide	NOUN
bam-9161	57	4	increased	increase	VERB
bam-9161	57	5	survival	survival	NOUN
bam-9161	57	6	rate	rate	NOUN
bam-9161	57	7	at	at	ADP
bam-9161	57	8	day	day	NOUN
bam-9161	57	9	100	100	NUM
bam-9161	57	10	to	to	PART
bam-9161	57	11	56	56	NUM
bam-9161	57	12	%	%	NOUN
bam-9161	57	13	(	(	PUNCT
bam-9161	57	14	most	most	ADJ
bam-9161	57	15	studies	study	NOUN
bam-9161	57	16	have	have	AUX
bam-9161	57	17	used	use	VERB
bam-9161	57	18	the	the	DET
bam-9161	57	19	dose	dose	NOUN
bam-9161	57	20	of	of	ADP
bam-9161	57	21	defibrotide	defibrotide	NOUN
bam-9161	57	22	of	of	ADP
bam-9161	57	23	25mg	25mg	ADJ
bam-9161	57	24	/	/	SYM
bam-9161	57	25	kg	kg	PROPN
bam-9161	57	26	/	/	SYM
bam-9161	57	27	day	day	NOUN
bam-9161	57	28	)	)	PUNCT
bam-9161	57	29	.	.	PUNCT
bam-9161	58	1	survival	survival	NOUN
bam-9161	58	2	in	in	ADP
bam-9161	58	3	patients	patient	NOUN
bam-9161	58	4	with	with	ADP
bam-9161	58	5	vod	vod	NOUN
bam-9161	58	6	without	without	ADP
bam-9161	58	7	mod	mod	NOUN
bam-9161	58	8	was	be	AUX
bam-9161	58	9	greater	great	ADJ
bam-9161	58	10	(	(	PUNCT
bam-9161	58	11	69	69	NUM
bam-9161	58	12	%	%	NOUN
bam-9161	58	13	)	)	PUNCT
bam-9161	58	14	than	than	ADP
bam-9161	58	15	in	in	ADP
bam-9161	58	16	patients	patient	NOUN
bam-9161	58	17	with	with	ADP
bam-9161	58	18	combined	combined	ADJ
bam-9161	58	19	vod	vod	NOUN
bam-9161	58	20	and	and	CCONJ
bam-9161	58	21	mod	mod	NOUN
bam-9161	58	22	(	(	PUNCT
bam-9161	58	23	42	42	NUM
bam-9161	58	24	%	%	NOUN
bam-9161	58	25	)	)	PUNCT
bam-9161	58	26	.	.	PUNCT
bam-9161	59	1	the	the	DET
bam-9161	59	2	definitions	definition	NOUN
bam-9161	59	3	used	use	VERB
bam-9161	59	4	for	for	ADP
bam-9161	59	5	multiorgan	multiorgan	NOUN
bam-9161	59	6	disorder	disorder	NOUN
bam-9161	59	7	in	in	ADP
bam-9161	59	8	these	these	DET
bam-9161	59	9	studies	study	NOUN
bam-9161	59	10	were	be	AUX
bam-9161	59	11	as	as	SCONJ
bam-9161	59	12	follows	follow	VERB
bam-9161	59	13	:	:	PUNCT
bam-9161	59	14	renal	renal	ADJ
bam-9161	59	15	dysfunction	dysfunction	NOUN
bam-9161	59	16	was	be	AUX
bam-9161	59	17	considered	consider	VERB
bam-9161	59	18	when	when	SCONJ
bam-9161	59	19	creatinine	creatinine	NOUN
bam-9161	59	20	≥	≥	NUM
bam-9161	59	21	3	3	NUM
bam-9161	59	22	×	×	NOUN
bam-9161	59	23	level	level	NOUN
bam-9161	59	24	at	at	ADP
bam-9161	59	25	time	time	NOUN
bam-9161	59	26	of	of	ADP
bam-9161	59	27	transplant	transplant	NOUN
bam-9161	59	28	,	,	PUNCT
bam-9161	59	29	or	or	CCONJ
bam-9161	59	30	creatinine	creatinine	NOUN
bam-9161	59	31	clearance	clearance	NOUN
bam-9161	59	32	/	/	SYM
bam-9161	59	33	gfr	gfr	NOUN
bam-9161	59	34	≤	≤	NUM
bam-9161	59	35	40	40	NUM
bam-9161	59	36	%	%	NOUN
bam-9161	59	37	of	of	ADP
bam-9161	59	38	baseline	baseline	NOUN
bam-9161	59	39	,	,	PUNCT
bam-9161	59	40	or	or	CCONJ
bam-9161	59	41	dialysis	dialysis	NOUN
bam-9161	59	42	dependence	dependence	NOUN
bam-9161	59	43	;	;	PUNCT
bam-9161	59	44	pulmonary	pulmonary	ADJ
bam-9161	59	45	dysfunction	dysfunction	NOUN
bam-9161	59	46	was	be	AUX
bam-9161	59	47	defined	define	VERB
bam-9161	59	48	by	by	ADP
bam-9161	59	49	saturation	saturation	NOUN
bam-9161	59	50	o2	o2	ADJ
bam-9161	59	51	≤	≤	NUM
bam-9161	59	52	90	90	NUM
bam-9161	59	53	%	%	NOUN
bam-9161	59	54	on	on	ADP
bam-9161	59	55	room	room	NOUN
bam-9161	59	56	air	air	NOUN
bam-9161	59	57	or	or	CCONJ
bam-9161	59	58	by	by	ADP
bam-9161	59	59	the	the	DET
bam-9161	59	60	need	need	NOUN
bam-9161	59	61	for	for	ADP
bam-9161	59	62	supplemental	supplemental	ADJ
bam-9161	59	63	oxygen	oxygen	NOUN
bam-9161	59	64	/	/	SYM
bam-9161	59	65	ventilator	ventilator	NOUN
bam-9161	59	66	dependence.1	dependence.1	VERB
bam-9161	59	67	according	accord	VERB
bam-9161	59	68	to	to	ADP
bam-9161	59	69	this	this	DET
bam-9161	59	70	systematic	systematic	ADJ
bam-9161	59	71	review	review	NOUN
bam-9161	59	72	,	,	PUNCT
bam-9161	59	73	the	the	DET
bam-9161	59	74	patients	patient	NOUN
bam-9161	59	75	with	with	ADP
bam-9161	59	76	vod	vod	NOUN
bam-9161	59	77	and	and	CCONJ
bam-9161	59	78	multi	multi	ADJ
bam-9161	59	79	-	-	ADJ
bam-9161	59	80	organ	organ	ADJ
bam-9161	59	81	dysfunction	dysfunction	NOUN
bam-9161	59	82	had	have	VERB
bam-9161	59	83	higher	high	ADJ
bam-9161	59	84	mortality	mortality	NOUN
bam-9161	59	85	,	,	PUNCT
bam-9161	59	86	and	and	CCONJ
bam-9161	59	87	those	those	PRON
bam-9161	59	88	who	who	PRON
bam-9161	59	89	used	use	VERB
bam-9161	59	90	defibrotide	defibrotide	NOUN
bam-9161	59	91	in	in	ADP
bam-9161	59	92	their	their	PRON
bam-9161	59	93	treatment	treatment	NOUN
bam-9161	59	94	had	have	VERB
bam-9161	59	95	higher	high	ADJ
bam-9161	59	96	survival.1	survival.1	ADP
bam-9161	59	97	early	early	ADJ
bam-9161	59	98	onset	onset	NOUN
bam-9161	59	99	of	of	ADP
bam-9161	59	100	treatment	treatment	NOUN
bam-9161	59	101	also	also	ADV
bam-9161	59	102	contributed	contribute	VERB
bam-9161	59	103	to	to	ADP
bam-9161	59	104	increased	increase	VERB
bam-9161	59	105	survival	survival	NOUN
bam-9161	59	106	.	.	PUNCT
bam-9161	60	1	the	the	DET
bam-9161	60	2	effect	effect	NOUN
bam-9161	60	3	seen	see	VERB
bam-9161	60	4	in	in	ADP
bam-9161	60	5	the	the	DET
bam-9161	60	6	dose	dose	NOUN
bam-9161	60	7	of	of	ADP
bam-9161	60	8	25mg	25mg	ADJ
bam-9161	60	9	/	/	SYM
bam-9161	60	10	kg	kg	ADJ
bam-9161	60	11	/	/	SYM
bam-9161	60	12	day	day	NOUN
bam-9161	60	13	of	of	ADP
bam-9161	60	14	defibrotide	defibrotide	NOUN
bam-9161	60	15	was	be	AUX
bam-9161	60	16	not	not	PART
bam-9161	60	17	different	different	ADJ
bam-9161	60	18	from	from	ADP
bam-9161	60	19	the	the	DET
bam-9161	60	20	higher	high	ADJ
bam-9161	60	21	doses	dose	NOUN
bam-9161	60	22	.	.	PUNCT
bam-9161	61	1	due	due	ADP
bam-9161	61	2	to	to	ADP
bam-9161	61	3	the	the	DET
bam-9161	61	4	anti	anti	ADJ
bam-9161	61	5	-	-	ADJ
bam-9161	61	6	thrombotic	thrombotic	ADJ
bam-9161	61	7	,	,	PUNCT
bam-9161	61	8	antiischemic	antiischemic	ADJ
bam-9161	61	9	and	and	CCONJ
bam-9161	61	10	thrombolytic	thrombolytic	ADJ
bam-9161	61	11	properties	property	NOUN
bam-9161	61	12	of	of	ADP
bam-9161	61	13	defibrotide	defibrotide	NOUN
bam-9161	61	14	and	and	CCONJ
bam-9161	61	15	the	the	DET
bam-9161	61	16	pathophysiology	pathophysiology	NOUN
bam-9161	61	17	of	of	ADP
bam-9161	61	18	vod	vod	NOUN
bam-9161	61	19	,	,	PUNCT
bam-9161	61	20	defibrotide	defibrotide	NOUN
bam-9161	61	21	is	be	AUX
bam-9161	61	22	thought	think	VERB
bam-9161	61	23	to	to	PART
bam-9161	61	24	be	be	AUX
bam-9161	61	25	effective	effective	ADJ
bam-9161	61	26	in	in	ADP
bam-9161	61	27	the	the	DET
bam-9161	61	28	prophylaxis	prophylaxis	NOUN
bam-9161	61	29	of	of	ADP
bam-9161	61	30	vod	vod	NOUN
bam-9161	61	31	.	.	PUNCT
bam-9161	62	1	studies	study	NOUN
bam-9161	62	2	have	have	AUX
bam-9161	62	3	been	be	AUX
bam-9161	62	4	conducted	conduct	VERB
bam-9161	62	5	to	to	PART
bam-9161	62	6	evaluate	evaluate	VERB
bam-9161	62	7	the	the	DET
bam-9161	62	8	side	side	NOUN
bam-9161	62	9	effects	effect	NOUN
bam-9161	62	10	of	of	ADP
bam-9161	62	11	defibrotide	defibrotide	NOUN
bam-9161	62	12	.	.	PUNCT
bam-9161	63	1	the	the	DET
bam-9161	63	2	overall	overall	ADJ
bam-9161	63	3	result	result	NOUN
bam-9161	63	4	was	be	AUX
bam-9161	63	5	that	that	PRON
bam-9161	63	6	defibrotide	defibrotide	NOUN
bam-9161	63	7	is	be	AUX
bam-9161	63	8	a	a	DET
bam-9161	63	9	safe	safe	ADJ
bam-9161	63	10	drug	drug	NOUN
bam-9161	63	11	and	and	CCONJ
bam-9161	63	12	the	the	DET
bam-9161	63	13	side	side	NOUN
bam-9161	63	14	effects	effect	NOUN
bam-9161	63	15	seen	see	VERB
bam-9161	63	16	in	in	ADP
bam-9161	63	17	treated	treat	VERB
bam-9161	63	18	patients	patient	NOUN
bam-9161	63	19	were	be	AUX
bam-9161	63	20	not	not	PART
bam-9161	63	21	different	different	ADJ
bam-9161	63	22	from	from	ADP
bam-9161	63	23	those	those	PRON
bam-9161	63	24	in	in	ADP
bam-9161	63	25	the	the	DET
bam-9161	63	26	control	control	NOUN
bam-9161	63	27	group	group	NOUN
bam-9161	63	28	.	.	PUNCT
bam-9161	64	1	most	most	ADJ
bam-9161	64	2	of	of	ADP
bam-9161	64	3	the	the	DET
bam-9161	64	4	side	side	NOUN
bam-9161	64	5	effects	effect	NOUN
bam-9161	64	6	reported	report	VERB
bam-9161	64	7	with	with	ADP
bam-9161	64	8	this	this	DET
bam-9161	64	9	drug	drug	NOUN
bam-9161	64	10	included	include	VERB
bam-9161	64	11	hemorrhage	hemorrhage	NOUN
bam-9161	64	12	and	and	CCONJ
bam-9161	64	13	hypotension	hypotension	NOUN
bam-9161	64	14	.	.	PUNCT
bam-9161	65	1	common	common	ADJ
bam-9161	65	2	hemorrhagic	hemorrhagic	NOUN
bam-9161	65	3	complications	complication	NOUN
bam-9161	65	4	include	include	VERB
bam-9161	65	5	pulmonary	pulmonary	ADJ
bam-9161	65	6	and	and	CCONJ
bam-9161	65	7	gastrointestinal	gastrointestinal	ADJ
bam-9161	65	8	bleeding	bleeding	NOUN
bam-9161	65	9	that	that	PRON
bam-9161	65	10	was	be	AUX
bam-9161	65	11	not	not	PART
bam-9161	65	12	different	different	ADJ
bam-9161	65	13	from	from	ADP
bam-9161	65	14	the	the	DET
bam-9161	65	15	control	control	NOUN
bam-9161	65	16	group.9	group.9	PROPN
bam-9161	65	17	in	in	ADP
bam-9161	65	18	a	a	DET
bam-9161	65	19	randomized	randomized	ADJ
bam-9161	65	20	bili	bili	NOUN
bam-9161	65	21	t	t	PROPN
bam-9161	65	22	,	,	PUNCT
bam-9161	65	23	bilirubin	bilirubin	NOUN
bam-9161	65	24	total	total	NOUN
bam-9161	65	25	;	;	PUNCT
bam-9161	65	26	bili	bili	PROPN
bam-9161	65	27	d	d	PROPN
bam-9161	65	28	,	,	PUNCT
bam-9161	65	29	bilirubin	bilirubin	NOUN
bam-9161	65	30	direct	direct	ADJ
bam-9161	65	31	.	.	PUNCT
bam-9161	66	1	alt	alt	ADJ
bam-9161	66	2	,	,	PUNCT
bam-9161	66	3	alanine	alanine	NOUN
bam-9161	66	4	aminotransferase	aminotransferase	PROPN
bam-9161	66	5	ast	ast	PROPN
bam-9161	66	6	,	,	PUNCT
bam-9161	66	7	aspartate	aspartate	NOUN
bam-9161	66	8	aminotransferase	aminotransferase	PROPN
bam-9161	66	9	wbc	wbc	PROPN
bam-9161	66	10	,	,	PUNCT
bam-9161	66	11	white	white	ADJ
bam-9161	66	12	blood	blood	NOUN
bam-9161	66	13	cell	cell	NOUN
bam-9161	66	14	;	;	PUNCT
bam-9161	66	15	hb	hb	PROPN
bam-9161	66	16	,	,	PUNCT
bam-9161	66	17	hemoglobin	hemoglobin	NOUN
bam-9161	66	18	;	;	PUNCT
bam-9161	66	19	plt	plt	NOUN
bam-9161	66	20	,	,	PUNCT
bam-9161	66	21	platelets	platelet	VERB
bam-9161	66	22	fig	fig	NOUN
bam-9161	66	23	3	3	X
bam-9161	66	24	.	.	PUNCT
bam-9161	66	25	laboratory	laboratory	NOUN
bam-9161	66	26	data	datum	NOUN
bam-9161	66	27	severe	severe	ADJ
bam-9161	66	28	veno	veno	NOUN
bam-9161	66	29	-	-	PUNCT
bam-9161	66	30	occlusive	occlusive	PROPN
bam-9161	66	31	disease	disease	NOUN
bam-9161	66	32	eur	eur	PROPN
bam-9161	66	33	j	j	PROPN
bam-9161	66	34	transl	transl	PROPN
bam-9161	66	35	myol	myol	NOUN
bam-9161	66	36	2020	2020	NUM
bam-9161	66	37	;	;	PUNCT
bam-9161	66	38	30	30	NUM
bam-9161	66	39	(	(	PUNCT
bam-9161	66	40	3	3	NUM
bam-9161	66	41	):	):	PUNCT
bam-9161	66	42	9161	9161	NUM
bam-9161	66	43	.	.	PUNCT
bam-9161	67	1	doi	doi	NOUN
bam-9161	67	2	:	:	PUNCT
bam-9161	67	3	10.4081	10.4081	NUM
bam-9161	67	4	/	/	SYM
bam-9161	67	5	ejtm.2020.9161	ejtm.2020.9161	ADJ
bam-9161	67	6	4	4	NUM
bam-9161	67	7	controlled	control	VERB
bam-9161	67	8	trial	trial	NOUN
bam-9161	67	9	,	,	PUNCT
bam-9161	67	10	defibrotide	defibrotide	NOUN
bam-9161	67	11	was	be	AUX
bam-9161	67	12	used	use	VERB
bam-9161	67	13	for	for	ADP
bam-9161	67	14	prophylaxis	prophylaxis	NOUN
bam-9161	67	15	in	in	ADP
bam-9161	67	16	356	356	NUM
bam-9161	67	17	high	high	ADJ
bam-9161	67	18	risk	risk	NOUN
bam-9161	67	19	pediatric	pediatric	ADJ
bam-9161	67	20	patients	patient	NOUN
bam-9161	67	21	and	and	CCONJ
bam-9161	67	22	the	the	DET
bam-9161	67	23	result	result	NOUN
bam-9161	67	24	of	of	ADP
bam-9161	67	25	the	the	DET
bam-9161	67	26	study	study	NOUN
bam-9161	67	27	was	be	AUX
bam-9161	67	28	that	that	SCONJ
bam-9161	67	29	in	in	ADP
bam-9161	67	30	the	the	DET
bam-9161	67	31	treatment	treatment	NOUN
bam-9161	67	32	group	group	NOUN
bam-9161	67	33	,	,	PUNCT
bam-9161	67	34	incidence	incidence	NOUN
bam-9161	67	35	of	of	ADP
bam-9161	67	36	vod	vod	NOUN
bam-9161	67	37	was	be	AUX
bam-9161	67	38	12	12	NUM
bam-9161	67	39	%	%	NOUN
bam-9161	67	40	versus	versus	ADP
bam-9161	67	41	20	20	NUM
bam-9161	67	42	%	%	NOUN
bam-9161	67	43	in	in	ADP
bam-9161	67	44	the	the	DET
bam-9161	67	45	placebo	placebo	NOUN
bam-9161	67	46	group	group	NOUN
bam-9161	67	47	(	(	PUNCT
bam-9161	67	48	risk	risk	NOUN
bam-9161	67	49	difference	difference	NOUN
bam-9161	67	50	7·7	7·7	NUM
bam-9161	67	51	%	%	NOUN
bam-9161	67	52	,	,	PUNCT
bam-9161	67	53	95	95	NUM
bam-9161	67	54	%	%	NOUN
bam-9161	67	55	ci	ci	NOUN
bam-9161	67	56	:	:	PUNCT
bam-9161	67	57	-15·3	-15·3	PROPN
bam-9161	67	58	to	to	ADP
bam-9161	67	59	-0·1	-0·1	NUM
bam-9161	67	60	;	;	PUNCT
bam-9161	67	61	log	log	NOUN
bam-9161	67	62	-	-	PUNCT
bam-9161	67	63	rank	rank	NOUN
bam-9161	67	64	test	test	NOUN
bam-9161	67	65	p=0·0507).10	p=0·0507).10	PROPN
bam-9161	67	66	work	work	NOUN
bam-9161	67	67	by	by	ADP
bam-9161	67	68	strouse	strouse	NOUN
bam-9161	67	69	and	and	CCONJ
bam-9161	67	70	colleagues	colleague	NOUN
bam-9161	67	71	in	in	ADP
bam-9161	67	72	2016	2016	NUM
bam-9161	67	73	has	have	AUX
bam-9161	67	74	confirmed	confirm	VERB
bam-9161	67	75	previous	previous	ADJ
bam-9161	67	76	results.8	results.8	PROPN
bam-9161	67	77	the	the	DET
bam-9161	67	78	study	study	NOUN
bam-9161	67	79	also	also	ADV
bam-9161	67	80	evaluated	evaluate	VERB
bam-9161	67	81	the	the	DET
bam-9161	67	82	incidence	incidence	NOUN
bam-9161	67	83	of	of	ADP
bam-9161	67	84	graft	graft	NOUN
bam-9161	67	85	-	-	PUNCT
bam-9161	67	86	versus	versus	ADP
bam-9161	67	87	-	-	PUNCT
bam-9161	67	88	host	host	NOUN
bam-9161	67	89	disease	disease	NOUN
bam-9161	67	90	(	(	PUNCT
bam-9161	67	91	gvhd	gvhd	NOUN
bam-9161	67	92	)	)	PUNCT
bam-9161	67	93	in	in	ADP
bam-9161	67	94	vod	vod	NOUN
bam-9161	67	95	patients	patient	NOUN
bam-9161	67	96	and	and	CCONJ
bam-9161	67	97	showed	show	VERB
bam-9161	67	98	the	the	DET
bam-9161	67	99	protective	protective	ADJ
bam-9161	67	100	effect	effect	NOUN
bam-9161	67	101	of	of	ADP
bam-9161	67	102	defibrotide	defibrotide	NOUN
bam-9161	67	103	on	on	ADP
bam-9161	67	104	the	the	DET
bam-9161	67	105	incidence	incidence	NOUN
bam-9161	67	106	and	and	CCONJ
bam-9161	67	107	severity	severity	NOUN
bam-9161	67	108	of	of	ADP
bam-9161	67	109	acute	acute	ADJ
bam-9161	67	110	gvhd	gvhd	NOUN
bam-9161	67	111	(	(	PUNCT
bam-9161	67	112	agvhd	agvhd	ADJ
bam-9161	67	113	)	)	PUNCT
bam-9161	67	114	.	.	PUNCT
bam-9161	68	1	the	the	DET
bam-9161	68	2	results	result	NOUN
bam-9161	68	3	were	be	AUX
bam-9161	68	4	that	that	SCONJ
bam-9161	68	5	the	the	DET
bam-9161	68	6	incidence	incidence	NOUN
bam-9161	68	7	of	of	ADP
bam-9161	68	8	grade	grade	NOUN
bam-9161	68	9	iii	iii	NOUN
bam-9161	68	10	-	-	PUNCT
bam-9161	68	11	iv	iv	NOUN
bam-9161	68	12	agvhd	agvhd	ADV
bam-9161	68	13	on	on	ADP
bam-9161	68	14	day	day	NOUN
bam-9161	68	15	100	100	NUM
bam-9161	68	16	was	be	AUX
bam-9161	68	17	lower	low	ADJ
bam-9161	68	18	in	in	ADP
bam-9161	68	19	the	the	DET
bam-9161	68	20	groups	group	NOUN
bam-9161	68	21	treated	treat	VERB
bam-9161	68	22	with	with	ADP
bam-9161	68	23	defibrotide	defibrotide	NOUN
bam-9161	68	24	than	than	ADP
bam-9161	68	25	in	in	ADP
bam-9161	68	26	the	the	DET
bam-9161	68	27	untreated	untreated	ADJ
bam-9161	68	28	groups	group	NOUN
bam-9161	68	29	.	.	PUNCT
bam-9161	69	1	the	the	DET
bam-9161	69	2	day	day	NOUN
bam-9161	69	3	100	100	NUM
bam-9161	69	4	cumulative	cumulative	ADJ
bam-9161	69	5	incidence	incidence	NOUN
bam-9161	69	6	of	of	ADP
bam-9161	69	7	agvhd	agvhd	NOUN
bam-9161	69	8	in	in	ADP
bam-9161	69	9	the	the	DET
bam-9161	69	10	treated	treat	VERB
bam-9161	69	11	group	group	NOUN
bam-9161	69	12	was	be	AUX
bam-9161	69	13	23.1	23.1	NUM
bam-9161	69	14	%	%	NOUN
bam-9161	69	15	while	while	SCONJ
bam-9161	69	16	it	it	PRON
bam-9161	69	17	was	be	AUX
bam-9161	69	18	37.7	37.7	NUM
bam-9161	69	19	%	%	NOUN
bam-9161	69	20	in	in	ADP
bam-9161	69	21	the	the	DET
bam-9161	69	22	untreated	untreated	ADJ
bam-9161	69	23	group	group	NOUN
bam-9161	69	24	,	,	PUNCT
bam-9161	69	25	with	with	ADP
bam-9161	69	26	an	an	DET
bam-9161	69	27	absolute	absolute	ADJ
bam-9161	69	28	difference	difference	NOUN
bam-9161	69	29	of	of	ADP
bam-9161	69	30	−14.6	−14.6	ADJ
bam-9161	69	31	%	%	NOUN
bam-9161	69	32	(	(	PUNCT
bam-9161	69	33	95	95	NUM
bam-9161	69	34	%	%	NOUN
bam-9161	69	35	ci	ci	NOUN
bam-9161	69	36	:	:	PUNCT
bam-9161	69	37	−33.6	−33.6	NUM
bam-9161	69	38	%	%	NOUN
bam-9161	69	39	to	to	PART
bam-9161	69	40	3.9	3.9	NUM
bam-9161	69	41	%	%	NOUN
bam-9161	69	42	)	)	PUNCT
bam-9161	69	43	.	.	PUNCT
bam-9161	70	1	corresponding	correspond	VERB
bam-9161	70	2	rates	rate	NOUN
bam-9161	70	3	for	for	ADP
bam-9161	70	4	grade	grade	NOUN
bam-9161	70	5	iii	iii	NOUN
bam-9161	70	6	-	-	PUNCT
bam-9161	70	7	iv	iv	NUM
bam-9161	70	8	agvhd	agvhd	NOUN
bam-9161	70	9	were	be	AUX
bam-9161	70	10	10.9	10.9	NUM
bam-9161	70	11	%	%	NOUN
bam-9161	70	12	of	of	ADP
bam-9161	70	13	the	the	DET
bam-9161	70	14	treated	treat	VERB
bam-9161	70	15	group	group	NOUN
bam-9161	70	16	and	and	CCONJ
bam-9161	70	17	28.6	28.6	NUM
bam-9161	70	18	%	%	NOUN
bam-9161	70	19	for	for	ADP
bam-9161	70	20	untreated	untreated	ADJ
bam-9161	70	21	groups	group	NOUN
bam-9161	70	22	,	,	PUNCT
bam-9161	70	23	with	with	ADP
bam-9161	70	24	an	an	DET
bam-9161	70	25	absolute	absolute	ADJ
bam-9161	70	26	difference	difference	NOUN
bam-9161	70	27	of	of	ADP
bam-9161	70	28	−17.7	−17.7	NOUN
bam-9161	70	29	%	%	NOUN
bam-9161	70	30	(	(	PUNCT
bam-9161	70	31	95	95	NUM
bam-9161	70	32	ci	ci	NOUN
bam-9161	70	33	:	:	PUNCT
bam-9161	70	34	−33.1	−33.1	ADJ
bam-9161	70	35	%	%	NOUN
bam-9161	70	36	to	to	ADP
bam-9161	70	37	−2.0	−2.0	PROPN
bam-9161	70	38	%	%	PROPN
bam-9161	70	39	)	)	PUNCT
bam-9161	70	40	.	.	PUNCT
bam-9161	71	1	they	they	PRON
bam-9161	71	2	attributed	attribute	VERB
bam-9161	71	3	this	this	DET
bam-9161	71	4	result	result	NOUN
bam-9161	71	5	to	to	ADP
bam-9161	71	6	the	the	DET
bam-9161	71	7	down	down	ADJ
bam-9161	71	8	regulation	regulation	NOUN
bam-9161	71	9	of	of	ADP
bam-9161	71	10	heparanase	heparanase	NOUN
bam-9161	71	11	or	or	CCONJ
bam-9161	71	12	inhibition	inhibition	NOUN
bam-9161	71	13	of	of	ADP
bam-9161	71	14	t	t	NOUN
bam-9161	71	15	cell	cell	NOUN
bam-9161	71	16	activity	activity	NOUN
bam-9161	71	17	with	with	ADP
bam-9161	71	18	the	the	DET
bam-9161	71	19	use	use	NOUN
bam-9161	71	20	of	of	ADP
bam-9161	71	21	defibrotide.10	defibrotide.10	NOUN
bam-9161	71	22	the	the	DET
bam-9161	71	23	patient	patient	NOUN
bam-9161	71	24	in	in	ADP
bam-9161	71	25	the	the	DET
bam-9161	71	26	present	present	ADJ
bam-9161	71	27	case	case	NOUN
bam-9161	71	28	report	report	NOUN
bam-9161	71	29	had	have	VERB
bam-9161	71	30	no	no	DET
bam-9161	71	31	common	common	ADJ
bam-9161	71	32	risk	risk	NOUN
bam-9161	71	33	factors	factor	NOUN
bam-9161	71	34	for	for	ADP
bam-9161	71	35	vod	vod	NOUN
bam-9161	71	36	;	;	PUNCT
bam-9161	71	37	she	she	PRON
bam-9161	71	38	was	be	AUX
bam-9161	71	39	not	not	PART
bam-9161	71	40	suffering	suffer	VERB
bam-9161	71	41	from	from	ADP
bam-9161	71	42	an	an	DET
bam-9161	71	43	underlying	underlie	VERB
bam-9161	71	44	liver	liver	NOUN
bam-9161	71	45	disease	disease	NOUN
bam-9161	71	46	before	before	ADP
bam-9161	71	47	transplant	transplant	NOUN
bam-9161	71	48	(	(	PUNCT
bam-9161	71	49	normal	normal	ADJ
bam-9161	71	50	serum	serum	NOUN
bam-9161	71	51	transaminase	transaminase	NOUN
bam-9161	71	52	level	level	NOUN
bam-9161	71	53	,	,	PUNCT
bam-9161	71	54	no	no	DET
bam-9161	71	55	active	active	ADJ
bam-9161	71	56	viral	viral	ADJ
bam-9161	71	57	hepatitis	hepatitis	NOUN
bam-9161	71	58	)	)	PUNCT
bam-9161	71	59	.	.	PUNCT
bam-9161	72	1	she	she	PRON
bam-9161	72	2	had	have	AUX
bam-9161	72	3	undergone	undergo	VERB
bam-9161	72	4	an	an	DET
bam-9161	72	5	autologous	autologous	ADJ
bam-9161	72	6	transplant	transplant	NOUN
bam-9161	72	7	,	,	PUNCT
bam-9161	72	8	where	where	SCONJ
bam-9161	72	9	vod	vod	NOUN
bam-9161	72	10	is	be	AUX
bam-9161	72	11	less	less	ADV
bam-9161	72	12	common	common	ADJ
bam-9161	72	13	.	.	PUNCT
bam-9161	73	1	the	the	DET
bam-9161	73	2	combination	combination	NOUN
bam-9161	73	3	of	of	ADP
bam-9161	73	4	clinical	clinical	ADJ
bam-9161	73	5	features	feature	NOUN
bam-9161	73	6	and	and	CCONJ
bam-9161	73	7	laboratory	laboratory	NOUN
bam-9161	73	8	studies	study	NOUN
bam-9161	73	9	prompted	prompt	VERB
bam-9161	73	10	us	we	PRON
bam-9161	73	11	to	to	PART
bam-9161	73	12	think	think	VERB
bam-9161	73	13	about	about	ADP
bam-9161	73	14	vod	vod	NOUN
bam-9161	73	15	and	and	CCONJ
bam-9161	73	16	start	start	VERB
bam-9161	73	17	defibrotide	defibrotide	NOUN
bam-9161	73	18	shortly	shortly	ADV
bam-9161	73	19	after	after	ADP
bam-9161	73	20	the	the	DET
bam-9161	73	21	onset	onset	NOUN
bam-9161	73	22	of	of	ADP
bam-9161	73	23	symptoms	symptom	NOUN
bam-9161	73	24	.	.	PUNCT
bam-9161	74	1	in	in	ADP
bam-9161	74	2	europe	europe	PROPN
bam-9161	74	3	,	,	PUNCT
bam-9161	74	4	defibrotide	defibrotide	NOUN
bam-9161	74	5	is	be	AUX
bam-9161	74	6	the	the	DET
bam-9161	74	7	only	only	ADJ
bam-9161	74	8	drug	drug	NOUN
bam-9161	74	9	approved	approve	VERB
bam-9161	74	10	for	for	ADP
bam-9161	74	11	the	the	DET
bam-9161	74	12	treatment	treatment	NOUN
bam-9161	74	13	of	of	ADP
bam-9161	74	14	vod	vod	NOUN
bam-9161	74	15	.	.	PUNCT
bam-9161	75	1	it	it	PRON
bam-9161	75	2	has	have	AUX
bam-9161	75	3	been	be	AUX
bam-9161	75	4	shown	show	VERB
bam-9161	75	5	to	to	PART
bam-9161	75	6	have	have	VERB
bam-9161	75	7	antithrombotic	antithrombotic	ADJ
bam-9161	75	8	and	and	CCONJ
bam-9161	75	9	anti	anti	ADJ
bam-9161	75	10	-	-	ADJ
bam-9161	75	11	inflammatory	inflammatory	ADJ
bam-9161	75	12	effects	effect	NOUN
bam-9161	75	13	and	and	CCONJ
bam-9161	75	14	may	may	AUX
bam-9161	75	15	promote	promote	VERB
bam-9161	75	16	revascularization	revascularization	NOUN
bam-9161	75	17	inducing	induce	VERB
bam-9161	75	18	endothelial	endothelial	ADJ
bam-9161	75	19	cell	cell	NOUN
bam-9161	75	20	proliferation	proliferation	NOUN
bam-9161	75	21	and	and	CCONJ
bam-9161	75	22	angiogenesis.11	angiogenesis.11	VERB
bam-9161	75	23	in	in	ADP
bam-9161	75	24	conclusion	conclusion	NOUN
bam-9161	75	25	,	,	PUNCT
bam-9161	75	26	vod	vod	NOUN
bam-9161	75	27	should	should	AUX
bam-9161	75	28	be	be	AUX
bam-9161	75	29	considered	consider	VERB
bam-9161	75	30	in	in	ADP
bam-9161	75	31	the	the	DET
bam-9161	75	32	differential	differential	ADJ
bam-9161	75	33	diagnosis	diagnosis	NOUN
bam-9161	75	34	of	of	ADP
bam-9161	75	35	hsct	hsct	NOUN
bam-9161	75	36	recipients	recipient	NOUN
bam-9161	75	37	who	who	PRON
bam-9161	75	38	present	present	VERB
bam-9161	75	39	with	with	ADP
bam-9161	75	40	unexplained	unexplained	ADJ
bam-9161	75	41	liver	liver	NOUN
bam-9161	75	42	injuries	injury	NOUN
bam-9161	75	43	,	,	PUNCT
bam-9161	75	44	ascites	ascite	NOUN
bam-9161	75	45	and/or	and/or	CCONJ
bam-9161	75	46	multi	multi	VERB
bam-9161	75	47	organ	organ	NOUN
bam-9161	75	48	failure	failure	NOUN
bam-9161	75	49	.	.	PUNCT
bam-9161	76	1	this	this	DET
bam-9161	76	2	case	case	NOUN
bam-9161	76	3	study	study	NOUN
bam-9161	76	4	has	have	AUX
bam-9161	76	5	suggested	suggest	VERB
bam-9161	76	6	that	that	SCONJ
bam-9161	76	7	one	one	NUM
bam-9161	76	8	way	way	NOUN
bam-9161	76	9	in	in	ADP
bam-9161	76	10	improving	improve	VERB
bam-9161	76	11	clinical	clinical	ADJ
bam-9161	76	12	outcomes	outcome	NOUN
bam-9161	76	13	for	for	ADP
bam-9161	76	14	patients	patient	NOUN
bam-9161	76	15	is	be	AUX
bam-9161	76	16	using	use	VERB
bam-9161	76	17	therapeutic	therapeutic	ADJ
bam-9161	76	18	treatment	treatment	NOUN
bam-9161	76	19	with	with	ADP
bam-9161	76	20	defibrotide	defibrotide	NOUN
bam-9161	76	21	.	.	PUNCT
bam-9161	77	1	specifically	specifically	ADV
bam-9161	77	2	,	,	PUNCT
bam-9161	77	3	early	early	ADJ
bam-9161	77	4	therapeutic	therapeutic	ADJ
bam-9161	77	5	intervention	intervention	NOUN
bam-9161	77	6	with	with	ADP
bam-9161	77	7	defibrotide	defibrotide	NOUN
bam-9161	77	8	can	can	AUX
bam-9161	77	9	improve	improve	VERB
bam-9161	77	10	the	the	DET
bam-9161	77	11	clinical	clinical	ADJ
bam-9161	77	12	outcomes	outcome	NOUN
bam-9161	77	13	of	of	ADP
bam-9161	77	14	these	these	DET
bam-9161	77	15	patients	patient	NOUN
bam-9161	77	16	.	.	PUNCT
bam-9161	78	1	list	list	NOUN
bam-9161	78	2	of	of	ADP
bam-9161	78	3	acronyms	acronym	NOUN
bam-9161	78	4	altalanine	altalanine	VERB
bam-9161	78	5	aminotransferase	aminotransferase	PROPN
bam-9161	78	6	ast	ast	PROPN
bam-9161	78	7	aspartate	aspartate	PROPN
bam-9161	78	8	aminotransferase	aminotransferase	PROPN
bam-9161	78	9	bili	bili	PROPN
bam-9161	79	1	d	d	PROPN
bam-9161	79	2	–	–	PUNCT
bam-9161	79	3	bilirubin	bilirubin	NOUN
bam-9161	79	4	direct	direct	ADJ
bam-9161	79	5	bili	bili	PROPN
bam-9161	79	6	t	t	PROPN
bam-9161	79	7	–	–	PUNCT
bam-9161	79	8	bilirubin	bilirubin	NOUN
bam-9161	79	9	total	total	ADJ
bam-9161	79	10	cmv	cmv	NOUN
bam-9161	79	11	cytomegalovirus	cytomegalovirus	NOUN
bam-9161	79	12	ebmt	ebmt	VERB
bam-9161	79	13	european	european	ADJ
bam-9161	79	14	society	society	NOUN
bam-9161	79	15	for	for	ADP
bam-9161	79	16	blood	blood	NOUN
bam-9161	79	17	and	and	CCONJ
bam-9161	79	18	marrow	marrow	PROPN
bam-9161	79	19	transplantation	transplantation	NOUN
bam-9161	79	20	gvhd	gvhd	NOUN
bam-9161	79	21	,	,	PUNCT
bam-9161	79	22	graft	graft	NOUN
bam-9161	79	23	-	-	PUNCT
bam-9161	79	24	versus	versus	ADP
bam-9161	79	25	-	-	PUNCT
bam-9161	79	26	host	host	NOUN
bam-9161	79	27	disease	disease	NOUN
bam-9161	79	28	hb	hb	PROPN
bam-9161	79	29	hemoglobin	hemoglobin	PROPN
bam-9161	79	30	hsct	hsct	PROPN
bam-9161	79	31	hematopoietic	hematopoietic	ADJ
bam-9161	79	32	stem	stem	NOUN
bam-9161	79	33	cell	cell	NOUN
bam-9161	79	34	transplantation	transplantation	NOUN
bam-9161	79	35	mibg	mibg	NOUN
bam-9161	79	36	–	–	PUNCT
bam-9161	79	37	metaiodobenzylguanidine	metaiodobenzylguanidine	NOUN
bam-9161	79	38	mod	mod	ADJ
bam-9161	79	39	multi	multi	ADJ
bam-9161	79	40	-	-	ADJ
bam-9161	79	41	organ	organ	ADJ
bam-9161	79	42	dysfunction	dysfunction	NOUN
bam-9161	79	43	opec	opec	PROPN
bam-9161	79	44	–	–	PUNCT
bam-9161	79	45	vincristine	vincristine	NOUN
bam-9161	79	46	,	,	PUNCT
bam-9161	79	47	prednisolone	prednisolone	PROPN
bam-9161	79	48	,	,	PUNCT
bam-9161	79	49	etoposide	etoposide	NOUN
bam-9161	79	50	and	and	CCONJ
bam-9161	79	51	chlorambucil	chlorambucil	PROPN
bam-9161	79	52	pai1	pai1	PROPN
bam-9161	79	53	–	–	PUNCT
bam-9161	79	54	plasminogen	plasminogen	NOUN
bam-9161	79	55	activator	activator	NOUN
bam-9161	79	56	inhibitor	inhibitor	NOUN
bam-9161	79	57	type	type	NOUN
bam-9161	79	58	1	1	NUM
bam-9161	79	59	pg	pg	NOUN
bam-9161	79	60	prostaglandin	prostaglandin	NOUN
bam-9161	79	61	plt	plt	NOUN
bam-9161	79	62	platelets	platelet	NOUN
bam-9161	79	63	sos	sos	PROPN
bam-9161	79	64	hepatic	hepatic	ADJ
bam-9161	79	65	sinusoidal	sinusoidal	ADJ
bam-9161	79	66	obstruction	obstruction	NOUN
bam-9161	79	67	syndrome	syndrome	NOUN
bam-9161	79	68	tm	tm	PROPN
bam-9161	79	69	thrombomodulin	thrombomodulin	PROPN
bam-9161	79	70	tx	tx	PROPN
bam-9161	79	71	–	–	PUNCT
bam-9161	79	72	thromboxaned	thromboxane	VERB
bam-9161	79	73	vegf	vegf	NOUN
bam-9161	79	74	–	–	PUNCT
bam-9161	79	75	vascular	vascular	ADJ
bam-9161	79	76	endothelial	endothelial	ADJ
bam-9161	79	77	growth	growth	NOUN
bam-9161	79	78	factor	factor	NOUN
bam-9161	79	79	vod	vod	PROPN
bam-9161	79	80	veno	veno	PROPN
bam-9161	79	81	-	-	PUNCT
bam-9161	79	82	occlusive	occlusive	NOUN
bam-9161	79	83	disease	disease	NOUN
bam-9161	79	84	wbc	wbc	PROPN
bam-9161	79	85	white	white	ADJ
bam-9161	79	86	blood	blood	NOUN
bam-9161	79	87	cell	cell	NOUN
bam-9161	79	88	authors	author	NOUN
bam-9161	79	89	contributions	contribution	VERB
bam-9161	79	90	gr	gr	PROPN
bam-9161	79	91	.	.	PUNCT
bam-9161	80	1	bahoush	bahoush	PROPN
bam-9161	80	2	planned	plan	VERB
bam-9161	80	3	the	the	DET
bam-9161	80	4	study	study	NOUN
bam-9161	80	5	and	and	CCONJ
bam-9161	80	6	edited	edit	VERB
bam-9161	80	7	final	final	ADJ
bam-9161	80	8	manuscript	manuscript	NOUN
bam-9161	80	9	.	.	PUNCT
bam-9161	81	1	m.vafapour	m.vafapour	PROPN
bam-9161	81	2	collected	collect	VERB
bam-9161	81	3	data	datum	NOUN
bam-9161	81	4	and	and	CCONJ
bam-9161	81	5	wrote	write	VERB
bam-9161	81	6	the	the	DET
bam-9161	81	7	preliminary	preliminary	ADJ
bam-9161	81	8	manuscript	manuscript	NOUN
bam-9161	81	9	.	.	PUNCT
bam-9161	82	1	acknowledgments	acknowledgment	NOUN
bam-9161	82	2	we	we	PRON
bam-9161	82	3	would	would	AUX
bam-9161	82	4	like	like	VERB
bam-9161	82	5	to	to	PART
bam-9161	82	6	thank	thank	VERB
bam-9161	82	7	both	both	PRON
bam-9161	82	8	our	our	PRON
bam-9161	82	9	patient	patient	NOUN
bam-9161	82	10	and	and	CCONJ
bam-9161	82	11	her	her	PRON
bam-9161	82	12	family	family	NOUN
bam-9161	82	13	for	for	ADP
bam-9161	82	14	letting	let	VERB
bam-9161	82	15	us	we	PRON
bam-9161	82	16	share	share	VERB
bam-9161	82	17	their	their	PRON
bam-9161	82	18	experience	experience	NOUN
bam-9161	82	19	.	.	PUNCT
bam-9161	83	1	funding	fund	VERB
bam-9161	83	2	none	none	NOUN
bam-9161	83	3	conflict	conflict	NOUN
bam-9161	83	4	of	of	ADP
bam-9161	83	5	interest	interest	NOUN
bam-9161	83	6	the	the	DET
bam-9161	83	7	authors	author	NOUN
bam-9161	83	8	declare	declare	VERB
bam-9161	83	9	they	they	PRON
bam-9161	83	10	have	have	VERB
bam-9161	83	11	no	no	DET
bam-9161	83	12	financial	financial	ADJ
bam-9161	83	13	,	,	PUNCT
bam-9161	83	14	personal	personal	ADJ
bam-9161	83	15	,	,	PUNCT
bam-9161	83	16	or	or	CCONJ
bam-9161	83	17	other	other	ADJ
bam-9161	83	18	conflicts	conflict	NOUN
bam-9161	83	19	of	of	ADP
bam-9161	83	20	interest	interest	NOUN
bam-9161	83	21	.	.	PUNCT
bam-9161	84	1	ethical	ethical	ADJ
bam-9161	84	2	publication	publication	NOUN
bam-9161	84	3	statement	statement	NOUN
bam-9161	84	4	we	we	PRON
bam-9161	84	5	confirm	confirm	VERB
bam-9161	84	6	that	that	SCONJ
bam-9161	84	7	we	we	PRON
bam-9161	84	8	have	have	AUX
bam-9161	84	9	read	read	VERB
bam-9161	84	10	the	the	DET
bam-9161	84	11	journal	journal	NOUN
bam-9161	84	12	’s	’s	PART
bam-9161	84	13	position	position	NOUN
bam-9161	84	14	on	on	ADP
bam-9161	84	15	issues	issue	NOUN
bam-9161	84	16	involved	involve	VERB
bam-9161	84	17	in	in	ADP
bam-9161	84	18	ethical	ethical	ADJ
bam-9161	84	19	publication	publication	NOUN
bam-9161	84	20	and	and	CCONJ
bam-9161	84	21	affirm	affirm	NOUN
bam-9161	84	22	that	that	SCONJ
bam-9161	84	23	this	this	DET
bam-9161	84	24	report	report	NOUN
bam-9161	84	25	is	be	AUX
bam-9161	84	26	consistent	consistent	ADJ
bam-9161	84	27	with	with	ADP
bam-9161	84	28	those	those	DET
bam-9161	84	29	guidelines	guideline	NOUN
bam-9161	84	30	.	.	PUNCT
bam-9161	85	1	corresponding	correspond	VERB
bam-9161	85	2	author	author	NOUN
bam-9161	85	3	golamreza	golamreza	PROPN
bam-9161	85	4	bahoush	bahoush	PROPN
bam-9161	85	5	,	,	PUNCT
bam-9161	85	6	ali	ali	PROPN
bam-9161	85	7	-	-	PUNCT
bam-9161	85	8	asghar	asghar	PROPN
bam-9161	85	9	children	children	PROPN
bam-9161	85	10	hospital	hospital	NOUN
bam-9161	85	11	,	,	PUNCT
bam-9161	85	12	faculty	faculty	NOUN
bam-9161	85	13	of	of	ADP
bam-9161	85	14	medicine	medicine	NOUN
bam-9161	85	15	,	,	PUNCT
bam-9161	85	16	iran	iran	PROPN
bam-9161	85	17	university	university	PROPN
bam-9161	85	18	of	of	ADP
bam-9161	85	19	medical	medical	ADJ
bam-9161	85	20	sciences	sciences	PROPN
bam-9161	85	21	,	,	PUNCT
bam-9161	85	22	tehran	tehran	PROPN
bam-9161	85	23	,	,	PUNCT
bam-9161	85	24	iran	iran	PROPN
bam-9161	85	25	.	.	PUNCT
bam-9161	86	1	orcid	orcid	NOUN
bam-9161	87	1	i	i	PRON
bam-9161	87	2	d	d	NOUN
bam-9161	87	3	:	:	PUNCT
bam-9161	87	4	0000	0000	NUM
bam-9161	87	5	-	-	PUNCT
bam-9161	87	6	0003	0003	NUM
bam-9161	87	7	-	-	PUNCT
bam-9161	87	8	1463	1463	NUM
bam-9161	87	9	-	-	SYM
bam-9161	87	10	9369	9369	NUM
bam-9161	87	11	email	email	NOUN
bam-9161	87	12	:	:	PUNCT
bam-9161	87	13	bahoush.gh@iums.ac.irm	bahoush.gh@iums.ac.irm	X
bam-9161	87	14	email	email	NOUN
bam-9161	87	15	and	and	CCONJ
bam-9161	87	16	orcid	orcid	NOUN
bam-9161	88	1	i	i	INTJ
bam-9161	88	2	d	d	PROPN
bam-9161	88	3	of	of	ADP
bam-9161	88	4	coauthor	coauthor	NOUN
bam-9161	88	5	laris	laris	PROPN
bam-9161	88	6	maryam	maryam	PROPN
bam-9161	88	7	vafapour	vafapour	PROPN
bam-9161	88	8	:	:	PUNCT
bam-9161	89	1	vafapourm@gmail.com	vafapourm@gmail.com	X
bam-9161	89	2	orcid	orcid	NOUN
bam-9161	90	1	i	i	PRON
bam-9161	90	2	d	d	NOUN
bam-9161	90	3	:	:	PUNCT
bam-9161	90	4	0000	0000	NUM
bam-9161	90	5	-	-	PUNCT
bam-9161	90	6	000223268363	000223268363	NUM
bam-9161	90	7	references	reference	NOUN
bam-9161	90	8	1	1	NUM
bam-9161	90	9	.	.	PUNCT
bam-9161	91	1	richardson	richardson	PROPN
bam-9161	91	2	p	p	PROPN
bam-9161	91	3	,	,	PUNCT
bam-9161	91	4	aggarwal	aggarwal	PROPN
bam-9161	91	5	s	s	PROPN
bam-9161	91	6	,	,	PUNCT
bam-9161	91	7	topaloglu	topaloglu	PROPN
bam-9161	91	8	o	o	NOUN
bam-9161	91	9	,	,	PUNCT
bam-9161	91	10	et	et	PROPN
bam-9161	91	11	al	al	PROPN
bam-9161	91	12	.	.	PUNCT
bam-9161	92	1	systematic	systematic	PROPN
bam-9161	92	2	review	review	NOUN
bam-9161	92	3	of	of	ADP
bam-9161	92	4	defibrotide	defibrotide	NOUN
bam-9161	92	5	studies	study	NOUN
bam-9161	92	6	in	in	ADP
bam-9161	92	7	the	the	DET
bam-9161	92	8	treatment	treatment	NOUN
bam-9161	92	9	of	of	ADP
bam-9161	92	10	veno	veno	NOUN
bam-9161	92	11	-	-	PUNCT
bam-9161	92	12	occlusive	occlusive	NOUN
bam-9161	92	13	disease	disease	NOUN
bam-9161	92	14	/	/	SYM
bam-9161	92	15	sinusoidal	sinusoidal	NOUN
bam-9161	92	16	obstruction	obstruction	NOUN
bam-9161	92	17	syndrome	syndrome	NOUN
bam-9161	92	18	(	(	PUNCT
bam-9161	92	19	vod	vod	NOUN
bam-9161	92	20	/	/	SYM
bam-9161	92	21	sos	sos	PROPN
bam-9161	92	22	)	)	PUNCT
bam-9161	92	23	.	.	PUNCT
bam-9161	93	1	bone	bone	NOUN
bam-9161	93	2	marrow	marrow	PROPN
bam-9161	93	3	transplant	transplant	PROPN
bam-9161	93	4	2019;54;1951–62	2019;54;1951–62	NUM
bam-9161	93	5	.	.	PUNCT
bam-9161	94	1	doi	doi	NOUN
bam-9161	94	2	:	:	PUNCT
bam-9161	94	3	10.1038	10.1038	NUM
bam-9161	94	4	/	/	SYM
bam-9161	94	5	s41409019	s41409019	VERB
bam-9161	94	6	0474	0474	NUM
bam-9161	94	7	-	-	SYM
bam-9161	94	8	8	8	NUM
bam-9161	94	9	2	2	NUM
bam-9161	94	10	.	.	PUNCT
bam-9161	94	11	corbacioglu	corbacioglu	PROPN
bam-9161	94	12	s	s	PROPN
bam-9161	94	13	,	,	PUNCT
bam-9161	94	14	carreras	carreras	PROPN
bam-9161	94	15	e	e	PROPN
bam-9161	94	16	,	,	PUNCT
bam-9161	94	17	ansari	ansari	PROPN
bam-9161	94	18	m	m	PROPN
bam-9161	94	19	,	,	PUNCT
bam-9161	94	20	et	et	PROPN
bam-9161	94	21	al	al	PROPN
bam-9161	94	22	.	.	PUNCT
bam-9161	95	1	diagnosis	diagnosis	NOUN
bam-9161	95	2	and	and	CCONJ
bam-9161	95	3	severity	severity	NOUN
bam-9161	95	4	criteria	criterion	NOUN
bam-9161	95	5	for	for	ADP
bam-9161	95	6	sinusoidal	sinusoidal	ADJ
bam-9161	95	7	obstruction	obstruction	NOUN
bam-9161	95	8	syndrome	syndrome	NOUN
bam-9161	95	9	/	/	SYM
bam-9161	95	10	veno	veno	NOUN
bam-9161	95	11	-	-	PUNCT
bam-9161	95	12	occlusive	occlusive	NOUN
bam-9161	95	13	disease	disease	NOUN
bam-9161	95	14	in	in	ADP
bam-9161	95	15	pediatric	pediatric	ADJ
bam-9161	95	16	patients	patient	NOUN
bam-9161	95	17	:	:	PUNCT
bam-9161	95	18	a	a	DET
bam-9161	95	19	new	new	ADJ
bam-9161	95	20	classification	classification	NOUN
bam-9161	95	21	from	from	ADP
bam-9161	95	22	the	the	DET
bam-9161	95	23	european	european	PROPN
bam-9161	95	24	society	society	NOUN
bam-9161	95	25	for	for	ADP
bam-9161	95	26	blood	blood	NOUN
bam-9161	95	27	and	and	CCONJ
bam-9161	95	28	marrow	marrow	PROPN
bam-9161	95	29	transplantation	transplantation	NOUN
bam-9161	95	30	.	.	PUNCT
bam-9161	96	1	bone	bone	NOUN
bam-9161	96	2	marrow	marrow	PROPN
bam-9161	96	3	transplant	transplant	PROPN
bam-9161	96	4	severe	severe	ADJ
bam-9161	96	5	veno	veno	NOUN
bam-9161	96	6	-	-	PUNCT
bam-9161	96	7	occlusive	occlusive	PROPN
bam-9161	96	8	disease	disease	NOUN
bam-9161	96	9	eur	eur	PROPN
bam-9161	96	10	j	j	PROPN
bam-9161	96	11	transl	transl	PROPN
bam-9161	96	12	myol	myol	NOUN
bam-9161	96	13	2020	2020	NUM
bam-9161	96	14	;	;	PUNCT
bam-9161	96	15	30	30	NUM
bam-9161	96	16	(	(	PUNCT
bam-9161	96	17	3	3	NUM
bam-9161	96	18	):	):	PUNCT
bam-9161	96	19	9161	9161	NUM
bam-9161	96	20	.	.	PUNCT
bam-9161	97	1	doi	doi	NOUN
bam-9161	97	2	:	:	PUNCT
bam-9161	98	1	10.4081	10.4081	NUM
bam-9161	98	2	/	/	SYM
bam-9161	98	3	ejtm.2020.9161	ejtm.2020.9161	ADJ
bam-9161	98	4	5	5	NUM
bam-9161	98	5	2018;53:138–45	2018;53:138–45	NUM
bam-9161	98	6	.	.	PUNCT
bam-9161	98	7	doi	doi	NOUN
bam-9161	98	8	:	:	PUNCT
bam-9161	98	9	10.1038	10.1038	NUM
bam-9161	98	10	/	/	SYM
bam-9161	98	11	bmt.2017.161	bmt.2017.161	ADJ
bam-9161	98	12	3	3	NUM
bam-9161	98	13	.	.	NOUN
bam-9161	98	14	mohty	mohty	PROPN
bam-9161	98	15	m	m	PROPN
bam-9161	98	16	,	,	PUNCT
bam-9161	98	17	malard	malard	PROPN
bam-9161	98	18	f	f	X
bam-9161	98	19	,	,	PUNCT
bam-9161	98	20	abecassis	abecassis	PROPN
bam-9161	98	21	m	m	PROPN
bam-9161	98	22	,	,	PUNCT
bam-9161	98	23	et	et	PROPN
bam-9161	98	24	al	al	PROPN
bam-9161	98	25	.	.	PROPN
bam-9161	98	26	sinusoidal	sinusoidal	ADJ
bam-9161	98	27	obstruction	obstruction	NOUN
bam-9161	98	28	syndrome	syndrome	NOUN
bam-9161	98	29	/	/	SYM
bam-9161	98	30	veno	veno	NOUN
bam-9161	98	31	-	-	PUNCT
bam-9161	98	32	occlusive	occlusive	NOUN
bam-9161	98	33	disease	disease	NOUN
bam-9161	98	34	:	:	PUNCT
bam-9161	98	35	current	current	ADJ
bam-9161	98	36	situation	situation	NOUN
bam-9161	98	37	and	and	CCONJ
bam-9161	98	38	perspectives	perspective	NOUN
bam-9161	98	39	-	-	PUNCT
bam-9161	98	40	a	a	DET
bam-9161	98	41	position	position	NOUN
bam-9161	98	42	statement	statement	NOUN
bam-9161	98	43	from	from	ADP
bam-9161	98	44	the	the	DET
bam-9161	98	45	european	european	PROPN
bam-9161	98	46	society	society	NOUN
bam-9161	98	47	for	for	ADP
bam-9161	98	48	blood	blood	NOUN
bam-9161	98	49	and	and	CCONJ
bam-9161	98	50	marrow	marrow	NOUN
bam-9161	98	51	transplantation	transplantation	NOUN
bam-9161	98	52	(	(	PUNCT
bam-9161	98	53	ebmt	ebmt	NOUN
bam-9161	98	54	)	)	PUNCT
bam-9161	98	55	.	.	PUNCT
bam-9161	99	1	bone	bone	NOUN
bam-9161	99	2	marrow	marrow	PROPN
bam-9161	99	3	transplant	transplant	PROPN
bam-9161	99	4	2015;50:781–9	2015;50:781–9	NUM
bam-9161	99	5	.	.	PUNCT
bam-9161	100	1	doi	doi	NOUN
bam-9161	100	2	:	:	PUNCT
bam-9161	100	3	10.1038	10.1038	NUM
bam-9161	100	4	/	/	SYM
bam-9161	100	5	bmt.2015	bmt.2015	NUM
bam-9161	100	6	.52	.52	NUM
bam-9161	100	7	4	4	NUM
bam-9161	100	8	.	.	PUNCT
bam-9161	101	1	carreras	carreras	PROPN
bam-9161	101	2	e	e	PROPN
bam-9161	101	3	,	,	PUNCT
bam-9161	101	4	diaz	diaz	PROPN
bam-9161	101	5	-	-	PUNCT
bam-9161	101	6	ricart	ricart	PROPN
bam-9161	101	7	m.	m.	NOUN
bam-9161	101	8	the	the	DET
bam-9161	101	9	role	role	NOUN
bam-9161	101	10	of	of	ADP
bam-9161	101	11	the	the	DET
bam-9161	101	12	endothelium	endothelium	NOUN
bam-9161	101	13	in	in	ADP
bam-9161	101	14	the	the	DET
bam-9161	101	15	short	short	ADJ
bam-9161	101	16	-	-	PUNCT
bam-9161	101	17	term	term	NOUN
bam-9161	101	18	complications	complication	NOUN
bam-9161	101	19	of	of	ADP
bam-9161	101	20	hematopoietic	hematopoietic	ADJ
bam-9161	101	21	sct	sct	PROPN
bam-9161	101	22	.	.	PUNCT
bam-9161	101	23	bone	bone	PROPN
bam-9161	101	24	marrow	marrow	PROPN
bam-9161	101	25	transplant	transplant	PROPN
bam-9161	101	26	2011;46:1495–502	2011;46:1495–502	X
bam-9161	101	27	.	.	PUNCT
bam-9161	101	28	doi	doi	NOUN
bam-9161	101	29	:	:	PUNCT
bam-9161	101	30	10.1038	10.1038	NUM
bam-9161	101	31	/	/	SYM
bam-9161	101	32	bmt.2011.65	bmt.2011.65	NUM
bam-9161	101	33	5	5	NUM
bam-9161	101	34	.	.	PUNCT
bam-9161	101	35	mohty	mohty	PROPN
bam-9161	101	36	m	m	PROPN
bam-9161	101	37	,	,	PUNCT
bam-9161	101	38	malard	malard	PROPN
bam-9161	101	39	f	f	X
bam-9161	101	40	,	,	PUNCT
bam-9161	101	41	abecassis	abecassis	PROPN
bam-9161	101	42	m	m	PROPN
bam-9161	101	43	,	,	PUNCT
bam-9161	101	44	et	et	PROPN
bam-9161	101	45	al	al	PROPN
bam-9161	101	46	.	.	PROPN
bam-9161	101	47	revised	revise	VERB
bam-9161	101	48	diagnosis	diagnosis	NOUN
bam-9161	101	49	and	and	CCONJ
bam-9161	101	50	severity	severity	NOUN
bam-9161	101	51	criteria	criterion	NOUN
bam-9161	101	52	for	for	ADP
bam-9161	101	53	sinusoidal	sinusoidal	ADJ
bam-9161	101	54	obstruction	obstruction	NOUN
bam-9161	101	55	syndrome	syndrome	NOUN
bam-9161	101	56	/	/	SYM
bam-9161	101	57	veno	veno	NOUN
bam-9161	101	58	-	-	PUNCT
bam-9161	101	59	occlusive	occlusive	NOUN
bam-9161	101	60	disease	disease	NOUN
bam-9161	101	61	in	in	ADP
bam-9161	101	62	adult	adult	NOUN
bam-9161	101	63	patients	patient	NOUN
bam-9161	101	64	:	:	PUNCT
bam-9161	101	65	a	a	DET
bam-9161	101	66	new	new	ADJ
bam-9161	101	67	classification	classification	NOUN
bam-9161	101	68	from	from	ADP
bam-9161	101	69	the	the	DET
bam-9161	101	70	european	european	PROPN
bam-9161	101	71	society	society	NOUN
bam-9161	101	72	for	for	ADP
bam-9161	101	73	blood	blood	NOUN
bam-9161	101	74	and	and	CCONJ
bam-9161	101	75	marrow	marrow	PROPN
bam-9161	101	76	transplantation	transplantation	NOUN
bam-9161	101	77	.	.	PUNCT
bam-9161	102	1	bone	bone	NOUN
bam-9161	102	2	marrow	marrow	PROPN
bam-9161	102	3	transplant	transplant	NOUN
bam-9161	102	4	2016;51:906–12	2016;51:906–12	PROPN
bam-9161	102	5	.	.	PUNCT
bam-9161	103	1	doi	doi	NOUN
bam-9161	103	2	:	:	PUNCT
bam-9161	103	3	10.1038	10.1038	NUM
bam-9161	103	4	/	/	SYM
bam-9161	103	5	bmt.2016.130	bmt.2016.130	PROPN
bam-9161	103	6	6	6	NUM
bam-9161	103	7	.	.	PUNCT
bam-9161	104	1	castellino	castellino	PROPN
bam-9161	104	2	a	a	X
bam-9161	104	3	,	,	PUNCT
bam-9161	104	4	guidi	guidi	PROPN
bam-9161	104	5	s	s	PROPN
bam-9161	104	6	,	,	PUNCT
bam-9161	104	7	dellacasa	dellacasa	PROPN
bam-9161	104	8	cm	cm	PROPN
bam-9161	104	9	,	,	PUNCT
bam-9161	104	10	et	et	PROPN
bam-9161	104	11	al	al	PROPN
bam-9161	104	12	.	.	PROPN
bam-9161	104	13	lateonset	lateonset	PROPN
bam-9161	104	14	hepatic	hepatic	PROPN
bam-9161	104	15	veno	veno	PROPN
bam-9161	104	16	-	-	PUNCT
bam-9161	104	17	occlusive	occlusive	NOUN
bam-9161	104	18	disease	disease	NOUN
bam-9161	104	19	after	after	ADP
bam-9161	104	20	allografting	allografte	VERB
bam-9161	104	21	:	:	PUNCT
bam-9161	104	22	report	report	NOUN
bam-9161	104	23	of	of	ADP
bam-9161	104	24	two	two	NUM
bam-9161	104	25	cases	case	NOUN
bam-9161	104	26	with	with	ADP
bam-9161	104	27	atypical	atypical	ADJ
bam-9161	104	28	clinical	clinical	ADJ
bam-9161	104	29	features	feature	NOUN
bam-9161	104	30	successfully	successfully	ADV
bam-9161	104	31	treated	treat	VERB
bam-9161	104	32	with	with	ADP
bam-9161	104	33	defibrotide	defibrotide	NOUN
bam-9161	104	34	.	.	PUNCT
bam-9161	105	1	mediterr	mediterr	PROPN
bam-9161	105	2	j	j	PROPN
bam-9161	105	3	hematol	hematol	PROPN
bam-9161	105	4	infect	infect	VERB
bam-9161	105	5	dis	dis	PROPN
bam-9161	105	6	2018;10	2018;10	NOUN
bam-9161	105	7	:	:	PUNCT
bam-9161	105	8	e2018001	e2018001	NOUN
bam-9161	105	9	.	.	PUNCT
bam-9161	106	1	doi	doi	NOUN
bam-9161	106	2	:	:	PUNCT
bam-9161	106	3	10.4084	10.4084	NUM
bam-9161	106	4	/	/	SYM
bam-9161	106	5	mjhid.2018.001	mjhid.2018.001	VERB
bam-9161	106	6	7	7	NUM
bam-9161	106	7	.	.	PUNCT
bam-9161	107	1	palomo	palomo	PROPN
bam-9161	107	2	m	m	PROPN
bam-9161	107	3	,	,	PUNCT
bam-9161	107	4	mir	mir	PROPN
bam-9161	107	5	e	e	PROPN
bam-9161	107	6	,	,	PUNCT
bam-9161	107	7	rovira	rovira	PROPN
bam-9161	107	8	m	m	PROPN
bam-9161	107	9	,	,	PUNCT
bam-9161	107	10	et	et	PROPN
bam-9161	107	11	al	al	PROPN
bam-9161	107	12	.	.	PUNCT
bam-9161	108	1	what	what	PRON
bam-9161	108	2	is	be	AUX
bam-9161	108	3	going	go	VERB
bam-9161	108	4	on	on	ADP
bam-9161	108	5	between	between	ADP
bam-9161	108	6	defibrotide	defibrotide	NOUN
bam-9161	108	7	and	and	CCONJ
bam-9161	108	8	endothelial	endothelial	ADJ
bam-9161	108	9	cells	cell	NOUN
bam-9161	108	10	?	?	PUNCT
bam-9161	109	1	snapshots	snapshot	NOUN
bam-9161	109	2	reveal	reveal	VERB
bam-9161	109	3	the	the	DET
bam-9161	109	4	hot	hot	ADJ
bam-9161	109	5	spots	spot	NOUN
bam-9161	109	6	of	of	ADP
bam-9161	109	7	their	their	PRON
bam-9161	109	8	romance	romance	NOUN
bam-9161	109	9	.	.	PUNCT
bam-9161	110	1	blood	blood	NOUN
bam-9161	110	2	2016;127:1719–27	2016;127:1719–27	PROPN
bam-9161	110	3	.	.	PUNCT
bam-9161	111	1	doi	doi	NOUN
bam-9161	111	2	:	:	PUNCT
bam-9161	111	3	10.1182	10.1182	NUM
bam-9161	111	4	/	/	SYM
bam-9161	111	5	blood2015	blood2015	PROPN
bam-9161	111	6	-	-	PUNCT
bam-9161	111	7	10	10	NUM
bam-9161	111	8	-	-	SYM
bam-9161	111	9	676114	676114	NUM
bam-9161	111	10	8	8	NUM
bam-9161	111	11	.	.	PUNCT
bam-9161	112	1	strouse	strouse	PROPN
bam-9161	112	2	c	c	PROPN
bam-9161	112	3	,	,	PUNCT
bam-9161	112	4	richardson	richardson	PROPN
bam-9161	112	5	p	p	PROPN
bam-9161	112	6	,	,	PUNCT
bam-9161	112	7	prentice	prentice	NOUN
bam-9161	112	8	g	g	NOUN
bam-9161	112	9	,	,	PUNCT
bam-9161	112	10	et	et	PROPN
bam-9161	112	11	al	al	PROPN
bam-9161	112	12	.	.	PROPN
bam-9161	112	13	defibrotide	defibrotide	PROPN
bam-9161	112	14	for	for	ADP
bam-9161	112	15	treatment	treatment	NOUN
bam-9161	112	16	of	of	ADP
bam-9161	112	17	severe	severe	ADJ
bam-9161	112	18	veno	veno	NOUN
bam-9161	112	19	-	-	PUNCT
bam-9161	112	20	occlusive	occlusive	NOUN
bam-9161	112	21	disease	disease	NOUN
bam-9161	112	22	in	in	ADP
bam-9161	112	23	pediatrics	pediatric	NOUN
bam-9161	112	24	and	and	CCONJ
bam-9161	112	25	adults	adult	NOUN
bam-9161	112	26	:	:	PUNCT
bam-9161	112	27	an	an	DET
bam-9161	112	28	exploratory	exploratory	ADJ
bam-9161	112	29	analysis	analysis	NOUN
bam-9161	112	30	using	use	VERB
bam-9161	112	31	data	datum	NOUN
bam-9161	112	32	from	from	ADP
bam-9161	112	33	the	the	DET
bam-9161	112	34	center	center	NOUN
bam-9161	112	35	for	for	ADP
bam-9161	112	36	international	international	ADJ
bam-9161	112	37	blood	blood	NOUN
bam-9161	112	38	and	and	CCONJ
bam-9161	112	39	marrow	marrow	PROPN
bam-9161	112	40	transplant	transplant	NOUN
bam-9161	112	41	research	research	NOUN
bam-9161	112	42	.	.	PUNCT
bam-9161	113	1	biol	biol	PROPN
bam-9161	113	2	blood	blood	NOUN
bam-9161	113	3	marrow	marrow	PROPN
bam-9161	113	4	transplant	transplant	PROPN
bam-9161	113	5	2016;22:1306–12	2016;22:1306–12	PROPN
bam-9161	113	6	.	.	PUNCT
bam-9161	114	1	doi	doi	NOUN
bam-9161	114	2	:	:	PUNCT
bam-9161	114	3	10.1016	10.1016	NUM
bam-9161	114	4	/	/	SYM
bam-9161	114	5	j.bbmt.2016.04.011	j.bbmt.2016.04.011	PROPN
bam-9161	114	6	9	9	NUM
bam-9161	114	7	.	.	PUNCT
bam-9161	115	1	richardson	richardson	PROPN
bam-9161	115	2	pg	pg	PROPN
bam-9161	115	3	,	,	PUNCT
bam-9161	115	4	riches	rich	NOUN
bam-9161	115	5	ml	ml	PROPN
bam-9161	115	6	,	,	PUNCT
bam-9161	115	7	kernan	kernan	NOUN
bam-9161	115	8	na	na	PROPN
bam-9161	115	9	,	,	PUNCT
bam-9161	115	10	et	et	PROPN
bam-9161	115	11	al	al	PROPN
bam-9161	115	12	.	.	PROPN
bam-9161	115	13	phase	phase	NOUN
bam-9161	115	14	3	3	NUM
bam-9161	115	15	trial	trial	NOUN
bam-9161	115	16	of	of	ADP
bam-9161	115	17	defibrotide	defibrotide	NOUN
bam-9161	115	18	for	for	ADP
bam-9161	115	19	the	the	DET
bam-9161	115	20	treatment	treatment	NOUN
bam-9161	115	21	of	of	ADP
bam-9161	115	22	severe	severe	ADJ
bam-9161	115	23	veno	veno	NOUN
bam-9161	115	24	-	-	PUNCT
bam-9161	115	25	occlusive	occlusive	NOUN
bam-9161	115	26	disease	disease	NOUN
bam-9161	115	27	and	and	CCONJ
bam-9161	115	28	multi	multi	ADJ
bam-9161	115	29	-	-	ADJ
bam-9161	115	30	organ	organ	ADJ
bam-9161	115	31	failure	failure	NOUN
bam-9161	115	32	.	.	PUNCT
bam-9161	116	1	blood	blood	NOUN
bam-9161	116	2	2016;127:1656–65	2016;127:1656–65	NOUN
bam-9161	116	3	.	.	PUNCT
bam-9161	117	1	doi	doi	NOUN
bam-9161	117	2	:	:	PUNCT
bam-9161	117	3	10.1182/	10.1182/	NUM
bam-9161	117	4	blood-2015	blood-2015	NOUN
bam-9161	117	5	-	-	PUNCT
bam-9161	117	6	10	10	NUM
bam-9161	117	7	-	-	PUNCT
bam-9161	117	8	676924	676924	NUM
bam-9161	117	9	10	10	NUM
bam-9161	117	10	.	.	PUNCT
bam-9161	118	1	corbacioglu	corbacioglu	PROPN
bam-9161	118	2	s	s	PROPN
bam-9161	118	3	,	,	PUNCT
bam-9161	118	4	cesaro	cesaro	PROPN
bam-9161	118	5	s	s	PROPN
bam-9161	118	6	,	,	PUNCT
bam-9161	118	7	faraci	faraci	PROPN
bam-9161	118	8	m	m	PROPN
bam-9161	118	9	,	,	PUNCT
bam-9161	118	10	et	et	PROPN
bam-9161	118	11	al	al	PROPN
bam-9161	118	12	.	.	PROPN
bam-9161	118	13	defibrotide	defibrotide	PROPN
bam-9161	118	14	for	for	ADP
bam-9161	118	15	prophylaxis	prophylaxis	NOUN
bam-9161	118	16	of	of	ADP
bam-9161	118	17	hepatic	hepatic	ADJ
bam-9161	118	18	venoocclusive	venoocclusive	NOUN
bam-9161	118	19	disease	disease	NOUN
bam-9161	118	20	in	in	ADP
bam-9161	118	21	paediatric	paediatric	ADJ
bam-9161	118	22	haemopoietic	haemopoietic	ADJ
bam-9161	118	23	stemcell	stemcell	PROPN
bam-9161	118	24	transplantation	transplantation	NOUN
bam-9161	118	25	:	:	PUNCT
bam-9161	118	26	an	an	DET
bam-9161	118	27	open	open	ADJ
bam-9161	118	28	-	-	PUNCT
bam-9161	118	29	label	label	NOUN
bam-9161	118	30	,	,	PUNCT
bam-9161	118	31	phase	phase	NOUN
bam-9161	118	32	3	3	NUM
bam-9161	118	33	,	,	PUNCT
bam-9161	118	34	randomized	randomize	VERB
bam-9161	118	35	controlled	control	VERB
bam-9161	118	36	trial	trial	NOUN
bam-9161	118	37	.	.	PUNCT
bam-9161	119	1	lancet	lancet	PROPN
bam-9161	119	2	2012;379:1301–9	2012;379:1301–9	NUM
bam-9161	119	3	.	.	PUNCT
bam-9161	120	1	doi	doi	NOUN
bam-9161	120	2	:	:	PUNCT
bam-9161	120	3	10.1016	10.1016	NUM
bam-9161	120	4	/	/	SYM
bam-9161	120	5	s0140	s0140	PROPN
bam-9161	120	6	-	-	PUNCT
bam-9161	120	7	6736(11	6736(11	NUM
bam-9161	120	8	)	)	PUNCT
bam-9161	120	9	61938	61938	NUM
bam-9161	120	10	-	-	SYM
bam-9161	120	11	7	7	NUM
bam-9161	120	12	11	11	NUM
bam-9161	120	13	.	.	PUNCT
bam-9161	121	1	richardson	richardson	PROPN
bam-9161	121	2	pg	pg	PROPN
bam-9161	121	3	,	,	PUNCT
bam-9161	121	4	elias	elias	PROPN
bam-9161	121	5	ad	ad	PROPN
bam-9161	121	6	,	,	PUNCT
bam-9161	121	7	krishnan	krishnan	PROPN
bam-9161	121	8	a	a	PROPN
bam-9161	121	9	,	,	PUNCT
bam-9161	121	10	et	et	PROPN
bam-9161	121	11	al	al	PROPN
bam-9161	121	12	.	.	PROPN
bam-9161	122	1	treatment	treatment	NOUN
bam-9161	122	2	of	of	ADP
bam-9161	122	3	severe	severe	ADJ
bam-9161	122	4	veno	veno	NOUN
bam-9161	122	5	-	-	PUNCT
bam-9161	122	6	occlusive	occlusive	NOUN
bam-9161	122	7	disease	disease	NOUN
bam-9161	122	8	with	with	ADP
bam-9161	122	9	defibrotide	defibrotide	NOUN
bam-9161	122	10	:	:	PUNCT
bam-9161	122	11	compassionate	compassionate	ADJ
bam-9161	122	12	use	use	NOUN
bam-9161	122	13	results	result	NOUN
bam-9161	122	14	in	in	ADP
bam-9161	122	15	response	response	NOUN
bam-9161	122	16	without	without	ADP
bam-9161	122	17	significant	significant	ADJ
bam-9161	122	18	toxicity	toxicity	NOUN
bam-9161	122	19	in	in	ADP
bam-9161	122	20	a	a	DET
bam-9161	122	21	high	high	ADJ
bam-9161	122	22	-	-	PUNCT
bam-9161	122	23	risk	risk	NOUN
bam-9161	122	24	population	population	NOUN
bam-9161	122	25	.	.	PUNCT
bam-9161	123	1	blood	blood	NOUN
bam-9161	123	2	1998	1998	NUM
bam-9161	123	3	;	;	PUNCT
bam-9161	123	4	92:737–44	92:737–44	NUM
bam-9161	123	5	.	.	PUNCT
bam-9161	124	1	doi	doi	NOUN
bam-9161	124	2	:	:	PUNCT
bam-9161	124	3	92(3):73744	92(3):73744	NUM
bam-9161	124	4	submission	submission	NOUN
bam-9161	124	5	:	:	PUNCT
bam-9161	124	6	june	june	PROPN
bam-9161	124	7	4	4	NUM
bam-9161	124	8	,	,	PUNCT
bam-9161	124	9	2020	2020	NUM
bam-9161	124	10	revision	revision	NOUN
bam-9161	124	11	received	receive	VERB
bam-9161	124	12	:	:	PUNCT
bam-9161	124	13	june	june	PROPN
bam-9161	124	14	15	15	NUM
bam-9161	124	15	,	,	PUNCT
bam-9161	124	16	2020	2020	NUM
bam-9161	124	17	accepted	accept	VERB
bam-9161	124	18	for	for	ADP
bam-9161	124	19	pubblication	pubblication	NOUN
bam-9161	124	20	:	:	PUNCT
bam-9161	124	21	june	june	PROPN
bam-9161	124	22	18	18	NUM
bam-9161	124	23	,	,	PUNCT
bam-9161	124	24	2020	2020	NUM